Zusammenfassung
Nachdem 1938 die erste elektrokonvulsive Behandlung eines schizophrenen Patienten stattgefunden hatte und zu dieser Zeit keine andere somatische Therapie depressiver Erkrankungen etabliert war, wurden in den 40er Jahren die ersten unter einer Depression leidenden Patienten durch eine Elektrokonvulsionstherapie (EKT) effektiv behandelt [173]. Durch die erstmalige Einf¨¹hrung einer biologischen Therapie depressiver Erkrankungen konnte die Mortalität und die Rate chronifizierter Erkrankungen gesenkt werden [20, 21, 125, 127, 176]. Nach der Etablierung der Antidepressiva im Gefolge der Einführung des Imipramins (1958) ging die Anwendungshäufigkeit der EKT zurück. Weiterhin blieb jedoch die Wirksamkeit der EKT in der Depressionstherapie ein Maßstab zur Beurteilung der Wirksamkeit einer Pharmakotherapie [173].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
The Northwick Park Clinical Research Centre (1984)The Northwick Park ECT trial. Predictors of response to real and simulated ECT. Clinical Research Centre, Division of Psychiatry. Br J Psychiatry 144: 227–237
Abrams R (1982) ECT and tricyclic antidepressants in the treatment of endogenous depression. Psychopharmacol Bull 18: 73–75
Abrams R (1997) Electroconvulsive Therapy. Oxford University Press, New York, Oxford
Abrams R (1997) The mortality rate with ECT. Convuls Ther 13: 125–127
Abrams R (2000) Use of ECT in Italy. Am J Psychiatry 157: 840
Abrams R (2002) Electroconvulsive Therapy. Oxford University Press, Oxford, New York
Abrams R, Fink M, Feldstein S (1973) Prediction of clinical response to ECT. Br J Psychiatry 122: 457–460
Abrams R, Swartz C M, Vedak C (1991) Antidepressant effects of high-dose right unilateral electroconvulsive therapy. Arch Gen Psychiatry 48: 746–748
Abrams R, Taylor M A (1974) Unipolar and bipolar depressive illness. Phenomenology and response to electroconvulsive therapy. Arch Gen Psychiatry 30: 320–321
Abrams R, Taylor M A (1976) Catatonia. A prospective clinical study. Arch Gen Psychiatry 33: 579–581
Agelink M W, Andrich J, PostertT, Wurzinger U, ZeitT, Klotz P, Przuntek H (2001) Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100.1 Neurol Neurosurg Psychiatry 71: 394–396
Allman P, Hawton K (1987) ECT for Poststroke Depression: Beta Blockade to Modify Rise in Blood Pressure. ConvulsTher 3: 218–221
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington DC, USA
Andrade C, Gangadhar B N, Channabasavanna S M (1987) Mania associated with electroconvulsive therapy. J Clin Psychiatry 48: 303–304
Andrade C, Gangadhar B N, Swaminath G, Channabasavanna S M (1988) Predicting the Outcome of Endogenous Depression Following Electroconvulsive Therapy. ConvulsTher 4: 169–174
Angst J, Angst K, Baruffol I, Meinherz-Surbeck R (1992) ECT-Induced and Drug-Induced Hypomania. ConvulsTher 8: 179–185
Aronson T A, Shukla S, Hoff A, Cook B (1988) Proposed delusional depression subtypes: preliminary evidence from a retrospective study of phenomenology and treatment course. J Affect Disord 14: 69–74
Auquier P, Hodgkinson M, Thirion X, Tramoni AV (1994) [Attitude of psychiatrists to electrotherapy]. Encephale 20: 713–717
Avery D, Lubrano A (1979) Depression treated with imipramine and ECT: the DeCarolis study reconsidered. Am J Psychiatry 136: 559–562
Avery D, Winokur G (1976) Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch Gen Psychiatry 33: 1029–1037
Babigian H M, Guttmacher L B (1984) Epidemiologic considerations in electroconvulsive therapy. Arch Gen Psychiatry 41: 246–253
Beale M D, Kellner C H, Pritchett J T, Burns C M (1995) ECT for OCD. J Clin Psychiatry 56: 81–82
Beliles K, Stoudemire A (1998) Psychopharmacologic treatment of depression in the medically ill. Psychosomatics 39: S2–19
Benadhira R, Teles A (2001) [Current status of electroconvulsive therapy in adult psychiatric care in France]. Encephale 27: 129–136
Bernardo M, Arrufat F, Pintor L, Catarineu S, Buisan E, Ballus C (1996) [Patterns of the use of electroconvulsive therapy in Barcelona]. Med Clin (Barc) 106: 201–204
Bernardo M, Arrufat F, Pintor L, Catarineu S, Buisan E, Ballus C (1996) [Patterns of the use of electroconvulsive therapy in Barcelona]. Med Clin (Barc) 106: 201–204
Bernardo M, Navarro V, Salva J, Arrufat F J, Baeza I (2000) Seizure activity and safety in combined treatment with venlafaxine and ECT: a pilot study. J ECT 16: 38–42
Bibb R C, Guze S B (1972) Hysteria (Briquet’s syndrome) in a psychiatric hospital: the significance of secondary depression. Am J Psychiatry 129: 224–228
Black D W, Bell S, Hulbert J, Nasrallah A (1988) The importance of Axis II in patients with major depression. A controlled study. J Affect Disord 14: 115–122
Black D W, Winokur G, Nasrallah A (1986) ECT in Unipolar and Bipolar Disorders: A Naturalistic Evaluation of 460 Patients. Convuls Ther 2: 231–237
Black D W, Winokur G, Nasrallah A (1989) Illness Duration and Acute Response in Major Depression. ConvulsTher 5: 338–343
Black D W, Winokur G, Nasrallah A (1993) A Multivariate Analysis of the Experience of 423 Depressed Inpatients Treated with ElectroconvulsiveTherapy. ConvulsTher 9: 112–120
Brandon S, Cowley P, McDonald C, Neville P, Palmer R, Wellstood-Eason S (1984) Electroconvulsive therapy: results in depressive illness from the Leicestershire trial. Br Med J (Clin Res Ed) 288: 22–25
Breakey W R, Kala A K (1977) Typhoid catatonia responsive to ECT. Br Med J 2: 357–359
Brodaty H, Berle D, Hickie I, Mason C (2001) „Side effects“ of ECT are mainly depressive phenomena and are independent of age. J Affect Disord 66: 237–245
Buchan H, Johnstone E, McPherson K, Palmer R L, Crow T J, Brandon S (1992) Who benefits from electroconvulsive therapy? Combined results of the Leicester and Northwick Park trials. Br J Psychiatry 160: 355–359
Bush G, Fink M, Petrides G, Dowling F, Francis A (1996) Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 93: 137–143
Calev A, Gaudino E A, Squires N K, Zervas I M, Fink M (1995) ECT and non-memory cognition: a review. Br J Clin Psychol 34 (Pt 4): 505–515
Calev A, Nigal D, Shapira B, Tubi N, Chazan S, Ben Yehuda Y, Kugelmass S, Lerer B (1991) Early and long-term effects of electroconvulsive therapy and depression on memory and other cognitive functions. J Nery Ment Dis 179: 526–533
Carney M W, Rogan P A, Sebastian J, Sheffield B (1976) A controlled comparative trial of unilateral and bilateral sinusoidal and pulse ECT in endogenous depression. PDM 7(9–12)8: 77–79
Casey D A, Davis M H (1994) Obsessive-compulsive disorder responsive to electroconvulsive therapy in an elderly woman. South Med J 87: 862–864
Chan C H, Janicak P G, Davis J M, Altman E, Andriukaitis S, Hedeker D (1987) Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. J Clin Psychiatry 48: 197–200
Cohen D, Taieb O, Flament M, Benoit N, Chevret S, Corcos M, Fossati P, Jeammet P, Allilaire J F, Basquin M (2000) Absence of cognitive impairment at long-term follow-up in adolescents treated with ECT for severe mood disorder. Am J Psychiatry 157: 460–462
Coryell W, Pfohl B, Zimmerman M (1985) Outcome Following ElectroconvulsiveTherapy: A Comparison of Primary and Secondary Depression. Convuls Ther 1: 10–14
Coryell W, Zimmerman M (1984) Outcome following ECT for primary unipolar depression: a test of newly proposed response predictors. Am J Psychiatry 141: 862–867
Davidson J, McLeod M, Law-Yone B, Linnoila M (1978) A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression. Arch Gen Psychiatry 35: 639–642
DeBattista C, Mueller K (2001) Is electroconvulsive therapy effective for the depressed patient with comorbid borderline personality disorder? J ECT 17: 91–98
Delva N J, Brunet D, Hawken E R, Kesteven R M, Lawson J S, Lywood D W, Rodenburg M, Waldron J J (2000) Electrical dose and seizure threshold: relations to clinical outcome and cognitive effects in bifrontal, bitemporal, and right unilateral ECT. J ECT 16: 361–369
DeQuardo J R, Tandon R (1988) Concurrent lithium therapy prevents ECT-induced switch to mania. J Clin Psychiatry 49: 167–168
Devanand D P, Decina P, Sackeim H A, Prudic J (1988) Status epilepticus following ECT in a patient receiving theophylline. J Clin Psychopharmacol 8: 153
Devanand D P, Dwork A J, Hutchinson E R, Bolwig T G, Sackeim H A (1994) Does ECT alter brain structure? Am J Psychiatry 151: 957–970
Devanand D P, Fitzsimons L, Prudic J, Sackeim H A (1995) Subjective side effects during electroconvulsive therapy. Convuls Ther 11: 232–240
Devanand D P, Sackeim H A, Decina P, Prudic J (1988) The development of mania and organic euphoria during ECT. J Clin Psychiatry 49: 69–71
Devanand D P, Verma A K, Tirumalasetti F, Sackeim H A (1991) Absence of cognitive impairment after more than 100 lifetime ECT treatments. Am J Psychiatry 148: 929–932
DietzfelbingerT, Möller H J, Steinmeier E M, Fimmers R (1990) Elektrokrampftherapie als Ultima ratio bei Antidepressiva-Nonrespondern. In: Möller H J (ed)Therapieresistenz unter Antidepressiva-Behandlung. Springer, Berlin Heidelberg New York, 176–185
Dinan T G, Barry S (1989) A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatr Scand 80: 97–100
Dunn C G, Quinlan D (1978) Indicators of E.C.T. response and non-response in the treatment of depression. J Clin Psychiatry 39: 620–622
el Ganzouri A R, lvankovich A D, Braverman B, McCarthy R (1985) Monoamine oxidase inhibitors: should they be discontinued preoperatively? Anesth Analg 64: 592–596
Flint A J, Rifat S L (1998)The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT. Int J Geriatr Psychiatry 13: 23–28
Folkerts H W, Michael N, Tolle R, Schonauer K, Mucke S, Schulze-Monking H (1997) Electroconvulsive therapy vs. paroxetine in treatment-resistant depression — a randomized study. Acta Psychiatr Scand 96: 334–342
Folstein M, Folstein S, McHugh P R (1973) Clinical predictors of improvement after electroconvulsive therapy of patients with schizophrenia, neurotic reactions, and affective disorders. Biol Psychiatry 7: 147–152
Franco-Bronson K (1996)The management of treatment-resistant depression in the medically ill. Psychiatr Clin North Am 19: 329–350
Freeman C P (1978) The therapeutic efficacy of electroconvulsive therapy (ECT). A double blind controlled trial of ECT and simulated ECT. Scott Med J 23: 71–75
Freeman C P, Basson J V, Crighton A (1978) Double-blind controlled trail of electroconvulsive therapy (E.C.T.) and simulated E.C.T. in depressive illness. Lancet 1: 738–740
Freese K J (1985) Can Patients Safely Undergo Electroconvulsive Therapy While Receiving Monoamine Oxidase Inhibitors? Convuls Ther 1: 190–194
Frey R, Schreinzer D, Heiden A, Kasper S (2001) [Use of electroconvulsive therapy in psychiatry]. Nervenarzt 72: 661–676
Gangadhar B N, Kapur R L, Kalyanasundaram S (1982) Comparison of electroconvulsive therapy with imipramine in endogenous depression: a double blind study. Br J Psychiatry 141: 367–371
Genz A, Krause P, Koch R D, Knorr W (1985) [Side effects of bilateral electroconvulsive therapy-comparative clinico-computer tomographic study]. Psychiatr Neurol Med Psychol (Leipz) 37: 197–204
Geretsegger C, Rochowanski E (1987) Electroconvulsive Therapy in Acute Life-Threatening Catatonia with Associated Cardiac and Respiratory Decompensation. Convuls Ther 3: 291295
Ghaziuddin N, Laughrin D, Giordani B (2000) Cognitive side effects of electroconvulsive therapy in adolescents. J Child Adolesc Psychopharmacol 10: 269–276
Glen T, Scott A I (1999) Rates of electroconvulsive therapy use in Edinburgh (1992–1997). J Affect Disord 54: 81–85
Glen T, Scott A I (2000) Variation in rates of electroconvulsive therapy use among consultant teams in Edinburgh (1993–1996). J Affect Disord 58: 75–78
Gonzalez-Pinto A, Gutierrez M, Gonzalez N, Elizagarate E, Perez De Heredia J L, Mico J A (2002) Efficacy and Safety of Venlafaxine-ECT Combination in Treatment-Resistant Depression. J Neuropsychiatry Clin Neurosci 14: 206–209
Greenblatt M, Grosser G H, Wechsler H A (1964) Differential response of hospitalized depressed patients in somatic therapy. Am J Psychiatry 935–943
Gregory S, Shawcross C R, Gill D (1985)The Nottingham ECT Study. A double-blind comparison of bilateral, unilateral and simulated ECT in depressive illness. Br J Psychiatry 146: 520–524
Grogan R, Wagner D R, Sullivan T, Labar D (1995) Generalized nonconvulsive status epilepticus after electroconvulsive therapy. Convuls Ther 11: 51–56
Hafeiz H B (1987) Psychiatric manifestations of enteric fever. Acta Psychiatr Scand 75: 6973
Heshe J, Roeder E (1976) Electroconvulsive therapy in Denmark. Br J Psychiatry 128: 241245
Hickie I, Mason C, Parker G, Brodaty H (1996) Prediction of ECT response: validation of a refined sign-based ( CORE) system for defining melancholia. Br J Psychiatry 169: 68–74
Hickie I, Parsonage B, Parker G (1990) Prediction of response to electroconvulsive therapy. Preliminary validation of a sign-based typology of depression. Br J Psychiatry 157: 65–71
Hill G E, Wong K C, Hodges M R (1977) Lithium carbonate and neuromuscular blocking agents. Anesthesiology 46: 122–126
b. Hofmann P, Wieselmann G, Herzog G, Zapotoczky H G (1993) Elektrokonvulsionstherapie (EKT) in Österreich. Eine Umfrage. Neuropsychiatrie 7: 204–206
Janicak P G, Davis J M, Gibbons R D, Ericksen S, Chang S, Gallagher P (1985) Efficacy of ECT: a metaanalysis. Am J Psychiatry 142: 297–302
Johnstone E C, Deakin J F, Lawler P, Frith C D, Stevens M, McPherson K, Crow J (1980)The Northwick Park electroconvulsive therapy trial. Lancet 2: 1317–1320
Kindler S, Shapira B, Hadjez J, Abramowitz M, Brom D, Lerer B (1991) Factors Influencing Response to Bilateral Electroconvulsive Therapy in Major Depression. Convuls Ther 7: 245–254
Kornstein S G, Schneider R K (2001) Clinical features of treatment-resistant depression. J Clin Psychiatry 62 [Suppl] 16: 18–25
Kramer B A (1999) Use of ECT in California, revisited: 1984–1994. J ECT 15: 245–251
Krause P, Genz A, Knorr W (1988) [Prospective study of the late sequelae of electroconvulsive treatment]. Psychiatr Neurol Med Psychol (Leipz) 40: 532–536
Kroessler D (1985) Relative Efficacy Rates for Therapies of Delusional Depression. Convuls Ther 1: 173–182
Krystal A D, Coffey C E (1997) Neuropsychiatric considerations in the use of electroconvulsive therapy. J Neuropsychiatry Clin Neurosci 9: 283–292
Kukopulos A, Reginaldi D, Tondo L, Bernabei A, Caliari B (1977) Spontaneous length of depression and response to ECT. Psychol Med 7: 625–629
Lambourn J, Gill D (1978) A controlled comparison of simulated and real ECT. Br J Psychiatry 133: 514–519
Latey R H, FahyT J (1988) Some influences on regional variation in frequency of prescription of electroconvulsive therapy. Br J Psychiatry 152: 196–200
Lauritzen L, Odgaard K, Clemmesen L, Lunde M, Ohrstrom J, Black C, Bech P (1996) Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand 94: 241–251
Lemstra A, Leentjens A F, van den Broek W W (1996) [Temporary results only in electroconvulsive therapy in therapy-resistant depression; retrospective study]. Ned Tijdschr Geneeskd 140: 260–264
Lisanby S H, Maddox J H, Prudic J, Devanand D P, Sackeim H A (2000) The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry 57: 581–590
Lykouras E, Malliaras D, Christodoulou G N, Moussas G, Christodoulou D,Tzonou A (1986) Delusional depression: phenomenology and response to treatment. Psychopathology 19: 157–164
Lykouras E, Malliaras D, Christodoulou G N, PapakostasY, Voulgari A, Tzonou A, Stefanis C (1986) Delusional depression: phenomenology and response to treatment. A prospective study. Acta Psychiatr Scand 73: 324–329
Magni G, Fisman M, Helmes E (1988) Clinical correlates of ECT-resistant depression in the elderly. J Clin Psychiatry 49: 405–407
Maletzky B, McFarland B, Burt A (1994) Refractory obsessive compulsive disorder and ECT. ConvulsTher 10: 34–42
Mann S C, Caroff S N, Bleier H R, Antelo R E, Un H (1990) ElectroconvulsiveTherapy of the Lethal Catatonia Syndrome. ConvulsTher 6: 239–247
Mann S C, Caroff S N, Bleier H R, Welz W K, Kling M A, Hayashida M (1986) Lethal catatonia. Am J Psychiatry 143: 1374–1381
Markowitz J S, Kellner C H, DeVane C L, Beale M D, Folk J, Burns C, Liston H L (2001) Intranasal sumatriptan in post-ECT headache: results of an open-label trial. J ECT 17: 280283
McCall WV (2001) Electroconvulsive therapy in the era of modern psychopharmacology. Int J Neuropsychopharmacol 4: 315–324
McCall WV, Reboussin D M, Weiner R D, Sackeim H A (2000) Titrated moderately supra-threshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Arch Gen Psychiatry 57: 438–444
McDonald I M, Perkins M, Marjerrison G, Podilsky M (1966) A controlled comparison of amitriptyline and electroconvulsive therapy in the treatment of depression. Am J Psychiatry 122: 1427–1431
Mellman L A, Gorman J M (1984) Successful treatment of obsessive-compulsive disorder with ECT. Am J Psychiatry 141: 596–597
Mollenberg 0 (1997) [Electroconvulsive therapy-anesthesiological procedures]. Anasthesiol Intensivmed Notfallmed Schmerzther 32: 593–603
Möller H J (1997) Therapieresistenz unter Antidepressiva: Definition, Epidemiologie and Risikofaktoren. In: Bauer M, Berghöfer A (eds) Therapieresistente Depressionen. Springer, Berlin Heidelberg, 3–15
Möller H J, Laux G, Kapfhammer H P (1999) Psychiatrie and Psychotherapie. Srpinger, Berlin, Heidelberg
Muller U, Klimke A, Janner M, Gaebel W (1998) [Electroconvulsive therapy in psychiatric clinics in Germany in 19951. Nervenarzt 69: 15–26
Mulsant B H, Haskett R F, Prudic J, Thase M E, Malone K M, Mann J J, Pettinati H M, Sackeim H A (1997) Low use of neuroleptic drugs in the treatment of psychotic major depression. Am J Psychiatry 154: 559–561
Murray G B, Shea V, Conn D K (1986) Electroconvulsive therapy for poststroke depression. J Clin Psychiatry 47: 258–260
Nelson J C, Price L H, Jatlow P I (1986) Neuroleptic dose and desipramine concentrations during combined treatment of unipolar delusional depression. Am J Psychiatry 143: 1151–1154
Nelson J P, Benjamin L (1989) Efficacy and Safety of Combined ECT and Tricyclic Antidepressant Drugs in the Treatment of Depressed Geriatric Patients. Convuls Ther 5: 321–329
Ng C, Schweitzer I, Alexopoulos P, Celi E, Wong L, Tuckwell V, Sergejew A, Tiller J (2000) Efficacy and cognitive effects of right unilateral electroconvulsive therapy. J ECT 16: 370–379
Nobler M S, Sackeim H A, Moeller J R, Prudic J, Petkova E, Waternaux C (1997) Quantifying the speed of symptomatic improvement with electroconvulsive therapy: comparison of alternative statistical methods. ConvulsTher 13: 208–221
O’Toole J K, Dyck G (1977) Report of psychogenic fever in catatonia responding to electroconvulsive therapy. Dis New Syst 38: 852–853
Pande A C, Grunhaus L J, Haskett R F, Greden J F (1990) Electroconvulsive therapy in delusional and non-delusional depressive disorder. J Affect Disord 19: 215–219
Parker G, Roy K, Hadzi-Pavlovic D, Pedic F (1992) Psychotic (delusional) depression: a metaanalysis of physical treatments. J Affect Disord 24: 17–24
Perris C, d’Elia G (1966) A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. IX. therapy and prognosis. Acta Psychiatr Scand [Suppl] 194: 153–171
Perry P J, Morgan D E, Smith R E, Tsuang M T (1982) Treatment of unipolar depression accompanied by delusions. ECT versus tricyclic antidepressant-antipsychotic combinations. J Affect Disord 4: 195–200
Peters S G, Wochos D N, Peterson G C (1984) Status epilepticus as a complication of concurrent electroconvulsive and theophylline therapy. Mayo Clin Proc 59: 568–570
Pettinati H M, Bonner K M (1984) Cognitive functioning in depressed geriatric patients with a history of ECT. Am J Psychiatry 141: 49–52
Philbrick K L, RummansT A (1994) Malignant catatonia. J Neuropsychiatry Clin Neurosci 6: 1–13
Philibert RA, Richards L, Lynch C F, Winokur G (1995) Effect of ECT on mortality and clinical outcome in geriatric unipolar depression. J Clin Psychiatry 56: 390–394
Pluijms E M, BirkenhagerT K, Huijbrechts I P, Moleman P (2002) Influence of resistance to antidepressant pharmacotherapy on short-term response to electroconvulsive therapy. J Affect Disord 69: 93–99
Post F (1972)The management and nature of depressive illnesses in late life: a follow-through study. Br J Psychiatry 121: 393–404
Prudic J, Devanand D P, Sackeim H A, Decina P, Kerr B (1989) Relative response of endogenous and non-endogenous symptoms to electroconvulsive therapy. J Affect Disord 16: 59–64
Prudic J, Haskett R F, Mulsant B, Malone K M, Pettinati H M, Stephens S, Greenberg R, Rifas S L, Sackeim H A (1996) Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 153: 985–992
Prudic J, Sackeim H A, Devanand D P (1990) Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 31: 287–296
Quitkin F M (1985) The importance of dosage in prescribing antidepressants. Br J Psychiatry 147: 593–597
Quitkin F M, McGrath P J, Stewart J W, Taylor B P, Klein D F (1996) Can the effects of antidepressants be observed in the first two weeks of treatment? Neuropsychopharmacology 15: 390–394
Quitkin F M, Rabkin J G, Ross D, McGrath P J (1984) Duration of antidepressant drug treatment. What is an adequate trial? Arch Gen Psychiatry 41: 238–245
Rabheru K, Persad E (1997) A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry 42: 476–484
Rao K M, Gangadhar B N, Janakiramaiah N (1993) Nonconvulsive Status Epilepticus after the Ninth Electroconvulsive Therapy. Convuls Ther 9: 128–129
Rasmussen K G, Rummans T A, Richardson J W (2002) Electroconvulsive therapy in the medically ill. Psychiatr Clin North Am 25: 177–193
Rasmussen K G, Zorumski C F (1993) Electroconvulsive therapy in patients taking theophylline. J Clin Psychiatry 54: 427–431
Reimherr F W, Hodges M R, Hill G E, Wong K C (1977) Prolongation of muscle relaxant effects by lithium carbonate. Am J Psychiatry 134: 205–206
Rifkin A (1988) ECT versus tricyclic antidepressants in depression: a review of the evidence. J Clin Psychiatry 49: 3–7
Rohland B M, Carroll BT, Jacoby R G (1993) ECT in the treatment of the catatonic syndrome. J Affect Disord 29: 255–261
Roose S P, Glassman A H, Walsh BT, Woodring S, Vital-Herne J (1983) Depression, delusions, and suicide. Am J Psychiatry 140: 1159–1162
Rothschild A J (1996) Management of psychotic, treatment-resistant depression. Psychiatr Clin North Am 19: 237–252
Rothschild AL Samson J A, Bessette M P, Carter-Campbell J T (1993) Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression. J Clin Psychiatry 54: 338–342
Rubin E H, Kinscherf D A, Figiel G S, Zorumski C F (1993) The nature and time course of cognitive side effects during electroconvulsive therapy in the elderly. J Geriatr Psychiatry N eu ro l 6: 78–83
Sackeim H A (2001) The definition and meaning of treatment-resistant depression. J Clin Psychiatry 62 [Suppl] 16: 10–17
Sackeim H A, Decina P, Kanzler M, Kerr B, Malitz S (1987) Effects of electrode placement on the efficacy of titrated, low-dose ECT. Am J Psychiatry 144: 1449–1455
Sackeim H A, Prudic J, Devanand D P, Decina P, Kerr B, Malitz S (1990) The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 10: 96–104
Sackeim H A, Prudic J, Devanand D P, Kiersky J E, Fitzsimons L, Moody B J, McElhiney M C, Coleman E A, Settembrino J M (1993) Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 328: 839–846
Sackeim H A, Prudic J, Devanand D P, Nobler M S, Lisanby S H, Peyser S, Fitzsimons L, Moody B J, Clark J (2000) A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 57: 425–434
Sackeim H A, Ross F R, Hopkins N, Calev L, Devanand D P (1987) Subjective Side Effects Acutely Following ECT: Associations with Treatment Modality and Clinical Response. Convuls Ther 3: 100–110
Sackeim H A, Rush A J (1995) Melancholia and response to ECT. Am J Psychiatry 152: 12421243
Sareen J, Enns M W, Guertin J E (2000) The impact of clinically diagnosed personality disorders on acute and one-year outcomes of electroconvulsive therapy. J ECT 16: 43–51
Sauer H, Lauter H (1987) [Electroconvulsive therapy. Il. Indications, contraindications and therapeutic technics of electroconvulsive therapy]. Nervenarzt 58: 210–218
Scott A I, Riddle W (1989) Status epilepticus after electroconvulsive therapy. Br J Psychiatry 155: 119–121
Scott A I, Rodger C R, Stocks R H, Shering A P (1992) Is old-fashioned electroconvulsive therapy more efficacious? A randomised comparative study of bilateral brief-pulse and bilateral sine-wave treatments. Br J Psychiatry 160: 360–364
Shiwach R S, Reid W H, Carmody T J (2001) An analysis of reported deaths following electroconvulsive therapy in Texas, 1993–1998. Psychiatr Sery 52: 1095–1097
Sobin C, Prudic J, Devanand D P, Nobler M S, Sackeim H A (1996) Who responds to electroconvulsive therapy? A comparison of effective and ineffective forms of treatment. Br J Psychiatry 169: 322–328
Solomon R L, Rich C L, Darko D F (1990) Antidepressant treatment and the occurrence of mania in bipolar patients admitted for depression. J Affect Disord 18: 253–257
Sonawal la S B, Fava M (2001) Severe depression: is there a best approach? CNS Drugs 15: 765–776
Soyka M, Niederecker M, Meyendorf R (1991) [Successful treatment of a therapy-refractory compulsive syndrome by electroconvulsive therapy]. Nervenarzt 62: 448–450
Spiker D G, Stein J, Rich C L (1985) Delusional Depression and Electroconvulsive Therapy: One Year Later. ConvulsTher 1: 167–172
Spiker D G, Weis, J C, Dealy R S, Griffin S1, Hanin I, Neil J F, Perel J M, Rossi A J, Soloff P H (1985)The pharmacological treatment of delusional depression. Am) Psychiatry 142: 430–436
Squire L R, Zouzounis J A (1986) ECT and memory: brief pulse versus sine wave. Am J Psychiatry 143: 596–601
Stek M L, Beekman AT, Verwey B (1997) [Electroconvulsive therapy in late life depression: a review]. Tijdschr Gerontol Geriatr 28: 106–112
Stromgren L S (1973) Unilateral versus bilateral electroconvulsive therapy. Investigations into the therapeutic effect in endogenous depression. Acta Psychiatr Scand [Suppl] 240: 8–65
Stromgren L S (1991) Electroconvulsive therapy in the Nordic countries, 1977–1987. Acta Psychiatr Scand 84: 428–434
Tauscher J, Neumeister A, Fischer P, Frey R, Kasper S (1997) [Electroconvulsive therapy in clinical practice]. Nervenarzt 68: 410–416
Taylor M A, Abrams R (1977) Catatonia. Prevalence and importance in the manic phase of manic-depressive illness. Arch Gen Psychiatry 34: 1223–1225
Tew J D Jr, Mulsant B H, Haskett R F, Prudic J, Thase M E, Crowe R R, Dolata D, Begley A E, Reynolds C F Ill, Sackeim H A (1999) Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry 156: 1865–1870
Thase M E, Friedman E S, Howland R H (2000) Venlafaxine and treatment-resistant depression. Depress Anxiety 12 [Suppl] 1: 55–62
van Waarde J A, Stek M L (2001) [Electroconvulsive therapy effective and safe in 55 patients aged 56 years and older with mood disorders and physical comorbidity]. Ned Tijdschr Geneeskd 145: 1693–1697
Warneke L (1993) Managing resistant depression. When patients do not respond to therapy. Can Fam Physician 39: 843–850
Weiner R D, Coffey C E, Folk J, Fochtmann L J, Greenberg R M, Isenberg K E, Kellner C H, Sackeim H A, Moench L M (2001) The Practice of Electroconvulsive Therapy. American Psychiatric Association, Washington
Weiner R D, Rogers H J, Davidson J R, Kahn E M (1986) Effects of electroconvulsive therapy upon brain electrical activity. Ann N Y Acad Sci 462: 270–281
Weiner R D, Rogers H J, Davidson J R, Squire L R (1986) Effects of stimulus parameters on cognitive side effects. Ann N Y Acad Sci 462: 315–325
Wesner R B, Winokur G (1989) The influence of age on the natural history of unipolar depression when treated with electroconvulsive therapy. Eur Arch Psychiatry Neurol Sci 238: 149–154
West E D (1981) Electric convulsion therapy in depression: a double-blind controlled trial. Br Med J (Clin Res Ed) 282: 355–357
Wolfersdorf M, Barg T, Konig F, Leibfarth M, Grunewald I (1995) Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use. Pharmacopsychiatry 28: 56–60
World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, Switzerland
Yatham L N, Kusumakar V, Parikh S V, Haslam D R, Matte R, Sharma V, Kennedy S (1997) Bipolar depression: treatment options. Can J Psychiatry 42 [Suppl] 2: 87S-91 S
Zimmerman M, Coryell W, Pfohl B (1985) The treatment validity of DSM-III melancholic subtyping. Psychiatry Res 16: 37–43
Zimmerman M, Coryell W, Stang] D, Pfohl B (1986) An American validation study of the Newcastle scale. Ill. Course during index hospitalization and six-month prospective follow-up. Acta Psychiatr Scand 73: 412–415
Zorumski C F, Rutherford J L, Burke W J, Reich T (1986) ECT in primary and secondary depression. J Clin Psychiatry 47: 298–300
Abou-Saleh MT, Coppen AJ (1988) Continuation therapy with antidepressants after electroconvulsive therapy. Convuls Ther 4: 263–268
Adli M, Baethge C, Langlitz N, Bauer M. High-dose antidepressant treatment in refractory major depression: a critical review (eingereicht)
Adli M, BerghöferA, Linden M, Heimchen H, Müller-Oerlinghausen B, MackertA, Stamm T, Bauer M (2002) Effectiveness and feasibility of a standardized stepwise drug treatment algorithm for inpatients with depressive disorders — results of a two-year observational study. J CI in Psychiatry 63: 782–790
Adli M, Kießlinger U, Smolka M, Linden M, Neu P, Bauer M (2001) Algorithm-guided treatment of depression compared to standard treatment as usual — results of a randomized controlled trial in depression. 22. AGNP-Symposium, September 26–29,2001, Nürnberg. Pharmacopsychiatry 34: 162
American Psychiatric Association (2000) Practice guidelines for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 157 [Suppl]: 1–45
American Psychiatric Association Committee on ElectroconvulsiveTherapy (2001)The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. 2nd edn. American Psychiatric Association, Washington, DC
Amsterdam JD (1991) Use of high dose tranylcypromine in resistant depression. In: Amsterdam JD (Hrsg) Advances in Neuropsychiatry and Psychopharmacology. Vol 2: Refractory depression. Raven Press, New York, pp 123–129
Amsterdam JD, Hornig-Rohan M (1996)Treatment algorithms in treatment-resistant depression. Psychiatr Clin North Am 19: 371–386
Anderson DN (1994) Early responses to electroconvulsive therapy [letter]. Br J Psychiatry 165: 119–120
Andrade C, Gangadhar BN, Swaminath G, Channabasavanna SM (1988) Predicting the outcome of endogenous depression following electronconvulsive therapy. Convuls Ther 4: 169–174
Aronson R, Offman HJ, Joffe RT, Naylor D (1996) Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Arch Gen Psychiatry 53: 842–848
Aronson TA, Shukla S, Hoff A (1987) Continuation therapy after ECT for delusional depression: a naturalistic study of prophylactic treatments and relapse. Convuls Ther 3: 251–259
Avery D, Lubrano A (1979) Depression treated with imipramine and ECT: the DeCarolis study reconsidered. Am J Psychiatry 136: 549–562
Bauer M, Döpfmer S (1999) Lithium augmentation in treatment-resistant depression — a meta-analysis of placebo-controlled studies. J CI in Psychopharmacol 19: 427–434
Bauer M, Forsthoff A, Baethge C, Adli M, BerghöferA, Döpfiner S, BschorT. Lithium augmentation therapy in refractory depression — update 2002 (eingereicht)
Bauer M, Hellweg R, Baumgartner A (1998a) Hochdosierte Thyroxinbehandlung bei therapieund prophylaxeresistenten Patienten mit affektiven Psychosen. Nervenarzt 69: 1019–1022
Bauer M, Hellweg R, Gräf KJ, Baumgartner A (1998b) Treatment of refractory depression with high-dose thyroxine. Neuropsychopharmacology 18: 444–455
Bauer M, Heimchen H (2000) Allgemeine Behandlungsprinzipien bei affektiven Störungen. In: Heimchen H, Henn F, Lauter H, Sartorius N (Hrsg) Psychiatrie der Gegenwart, Bd. 5: Schizophrene und affektive Störungen. Springer, Berlin Heidelberg, S 475–493
Bauer M, Whybrow PC, Angst J, Versiani M, Möller HJ (2002) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder. World J Biol Psychiatry 3: 5–43
Bauer M, Whybrow PC, Angst J, Versiani M, Möller HJ (2002) World Federation of Societies of Biological Psychiatry (WFSBP): Guidelines for Biological Treatment of Unipolar Depressive Disorder, Part 2: MaintenanceTreatment of Major Depressive Disorder and Treatment of Chronic Depressive Disorders and Subthreshold Depressions. World J Biol Psychiatry 3: 67–84
Benbow SM (1989)The role of electroconvulsive therapy in the treatment of depressive illness in old age. Br J Psychiatry 155: 147–152
BerghöferA, Müller EB, Bauer M, Linden M, MackertA, Müller-Oerlinghausen B, Heimchen H (1997) Sequentiel le Behandlungsstrategien zur Vermeidung und Überwindung von Therapieresistenz bei depressiven Erkrankungen. In: Bauer M, Berghöfer A (Hrsg) Therapieresistente Depressionen. Aktueller Wissensstand and Leitlinien für die Behandlung in Klinik and Praxis. Springer, Berlin Heidelberg New York, S 235–243
Black DW; Winokur G, Nasrallah A (1987) The treatment of depression: electroconvulsive therapy v antidepressants: a naturalistic evaluation of 1,495 patients. Compr Psychiatry 28: 169–182
Bourgon LN, Kellner CH (2000) Relapse of depression after ECT: a review. J ECT 16: 19–31
Bourne H (1954) Convulsion dependence. Lancet 2: 1193–1196
Brandon S, Cowley P, McDonald C, Neville P, Palmer R, Wellstood-Eason S (1984) Electroconvulsive therapy: results in depressive illness from the Leceisthershire trial. BMJ 288: 22–25
Bratfos O, Haug JO (1965) Electroconvulsive therapy and antidepressant drugs in manic-depressive disease. Treatment results at discharge and 3 months later. Acta Psychiatr Scand 41: 588–596.
Buchan H, Johnstone E, McPherson K, Palmer RL, Crow TJ, Brandon S (1992) Who benefits from electroconvulsive therapy ? Combined results of the Leicester and Northwick Park trials. Br J Psychiatry 160: 335–359
Clarke TB, Coffey CE, Hoffmann GW, Weiner RD (1989) Continuation therapy for depression using outpatient electroconvulsive therapy. Convuls Ther 5: 330–337
Coppen A, Abou-Saleh MT, Milln P, Bailey), Metcalfe M, Burns BH, Armond A (1981) Lithium continuation therapy following electroconvulsive therapy. Br J Psychiatry 139: 284–287
Coryell W (2000) Augmentation strategies for inadequate antidepressant response: a review of placebo-controlled studies. Ann Clin Psychiatry 12: 141–146
Coryell W, Akiskal HS, Leon AC, Winokur G, Maser JD, Mueller TI, Keller MB (1994) The time course of non-chronic major depressive disorder. Arch Gen Psychiatry 51: 405–410
Coryell W, Zimmermann M (1983)The dexamethasone suppression test and ECT outcome: a six-month follow-up. Biol Psychiatry 18: 21–27
Cosgriff JP, Abbott RM, Oakley-Browne MA, Joyce PR (1990) Cortisol hypersecretion predicts early depressive relapse after recovery with electroconvulsive therapy. Biol Psychiatry 28: 1007–1010
Danish University Antidepressant Group [DUAL] (1999) Clomipramine dose-effect study in patients with depression: clinical end points and pharmacokinetics. Clin Pharmacol Ther 66: 152–165
Davidson J, McLeod M, Law-Yone B, Linnoila M (1978) A comparison of electroconvulsive therapy and combined phenelzin-amitriptyline in refractory depression. Arch Gen Psych 35: 639–642
DeBattista C, Mueller K (2001) Is electroconvulsive therapy effective for the depressed patient with comorbid borderline personality disorder ? J ECT 17: 91–98
DeCarolis V, Giberti F, Roccataglia G (1964) Imipramina ed elettroshock nella terapia delle depressioni: analisi clinico-statisica dei risutanti in 437 casi. Sistema Nervosa 1: 28–42
Decina P, Guthrie EB, Sackeim HA, Kahn D, Malitz 5 (1987a) Continuation ECT in the management of relapses of major affective episodes. Acta Psychiatr Scand 75: 559–562
Decina P, Sackeim HA, Kahn DA, Pierson D, Hopkins N, Malitz S (1987b) Effects of ECT on the TRH stimulation test. Psychoneuroendocrinology 12: 29–34
Deutsche Gesellschaft für Psychiatrie, Psychotherapie and Nervenheilkunde (DGPPN) (2000) Praxisleitlinien in Psychiatrie and Psychotherapie; Band 5: Behandlungsleitlinie Affektive Erkrankungen, Steinkopff, Darmstadt
Devanand DP, Sackeim HA, Prudic J (1991) Electroconvulsive therapy in the treatment-resistant patient. Psychiatr Clin North Am14: 905–923
Dinan TG, Barry S (1989) A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatr Scand 80: 97–100
Dunn CG, Quinlan D (1978) Indicators of ECT response and non-response in the treatment of depression. J Clin Psychiatry 39: 620–622
Fink M (2001) Electroconvulsive therapy in medication-resistant depression. In: Amsterdam J, Hornig M, NierenbergA (eds) Treatment-resistant mood disorders. Cambridge University Press, Cambridge, pp 223–238
Fink M, Gujavarty K, Greenberg L (1987) Serial dexamethasone suppression tests and clinical outcome in ECT. ConvulsTher 3: 111–120
Fink M (1979) Convulsive Therapy: Theory and Practice. Raven Press, New York
Flint AJ (1997) The impact of treatment resistance on depressive relapse following electroconvulsive therapy. Acta Psych iatr Scand 96: 405–406
Flint AJ, Rifat SL (1998) The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT. Int J Geriatr Psychiatry 13: 23–28
Folkerts H (1995) Elektrokrampftherapie—„Schocktherapie” oder ein differenziertes Behand I ungsverfahren. Deutsches Ärzteblatt 92: A358–364
Folkerts H (1997) Der Stellenwert der Elektrokrampftherapie b ei therapieresistenten Depressionen. In: Bauer M, Berghöfer A (Hrsg)Therapieresistente Depressionen. Aktueller Wissensstand und Leitlinien für die Behandlung in Klinik und Praxis. Springer, Berlin Heidelberg New York, S 187–197
Folkerts H (1998) Elektrokrampftherapie — Monitoring, Effektivität und pathischer Aspekt. Monographien aus dem Gesamtgebiet der Psychiatrie. Springer, Berlin, Heidelberg, New York
Folkerts H, Tölle MN, Schonauer K, Mücke S, Schulze-Winking H (1997) Electroconvulsive therapy vs. paroxetine in treatment-resistant depression — a randomized study. Acta Psychiatr Scand 96: 334–342
Fraser RM, Glass IB (1980) Unilateral and bilateral ECT in elderly patients: a comparative study. Acta Psychiatar Scand 62: 13–31
Freeman CP, Basson JV, Crighton A (1978) Double-blind controlled trial of electroconvulsive therapy ( ECT) and simulated ECT in depressive illness. Lancet 1: 738–740
Frey R, Schreinzer D, Heiden A, Kasper S (2001) Einsatz der Elektrokrampftherapie in der Psychiatrie. Nervenarzt 72: 661–676
Gaebel W, Falkai P (1996) Entwurf von DGPPN-Leitlinien zur Indikation und Durchführung der Elektrokrampftherapie ( EKT ). Nervenarzt 67: 509–514
Gagné GG, Furman MJ, Carpenter LL, Price LH (2000) Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry 157: 1960–1965
Glass RM (2001) Electroconvulsive Therapy. Time to bring it out of the shadows. JAMA 285: 1346–1348
Gregory S, Shawcross CR, Gill D (1985)The Nottingham ECT Study. A double-blind comparison of bilateral, unilateral and simulated ECT in depressive illness. Br J Psychiatry 146: 520–524
Grunhaus L, Shipley JE, Eiser A, Pande AC, Tandon R, Remen A, Greden JF (1994) Shortened REM latency post ECT is associated with rapid recurrence of depressive symptomatology. Biol Psychiatry 36: 214–22
Gupta S, Austin R, Devanand DP (1998) Lithium and maintenance electroconvulsive therapy. J ECT 14: 241–244
Hamilton M (1974) Drug resistant depressions: response to ECT. Pharmakopsychiatrie 7: 205206
Hamilton M, White J (1960) Factors related to the outcome of depression treated with ECT. J Ment Sci 106: 1031–1041
Heinz A (1997) Experimentelle Behandlungsansätze and Zukunftsperspektiven bei therapieresistenten Depressionen. In: Bauer M, Berghöfer A (Hrsg)Therapieresistente Depressionen. Aktueller Wissensstand and Leitlinien für die Behandlung in Klinik and Praxis. Springer, Berlin Heidelberg New York, S 152–169
Heimchen H (1990) Gestuftes Vorgehen bei Resistenz gegen Antidepressiva-Therapie. In: Möller HJ (Hrsg) Therapieresistenz unter Antidepressiva-Behandlung. Springer, Berlin Heidelberg New York, S 237–250
Hobson RF (1953) Prognostic factors in ECT. J Neurol Neurosurg Psychiatry 16: 275–281
Imlah NW, Ryan E, Harrington JA (1965)The influence of antidepressant drugs on the response to electroconvulsive therapy and on subsequent relapse rates. Neuropsychopharmacology 4: 438–442
Janicak PG, Easton M, Comaty JE, Dowd S, David JM (1989) Efficacy of ECT in psychotic and non-psychotic depression. Convuls Ther 5: 314–320
Joffe RT, Singer W (1990) A comparison of triiodthyronine and thyroxine in the potentiation of tricyclic antidepressants. Psychiatry Res 32: 241–251
Joffe RT, Singer W, Levitt At MacDonald C (1993) A placebo-controlled comparison of lithium and triiodthyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry 50: 387–393
Johnstone EC, Deakin JF, Lawler P, Frith CD, Stevens M, McPherson K (1980)The Northwick Park electroconvulsive therapy trial. Lancet 2: 1317–1320
Katona CLE, Aldridge CR (1984) Prediction of ECT response. Neuropharmacology 23: 281–283
Katona CLE, Aldridge CR, Roth M, Hyde J (1987) The dexamethasone suppression test and prediction of outcome in patients receiving ECT. Br J Psychiatry 150: 315–318
Kay DWK, Kahy T, Garside RF (1970) A 7-month double-blind trial of amitriptyline and diazepam in ECT-treated depressed patients. Br J Psychiatry 117: 667–671
Kindler S, Shapira B, Hadjez J, Abramowitz M, Brom D, Lerer B (1991) Factors influencing response to bilateral electroconvulsive therapy in major depression. ConvulsTher 7: 245–254
Kirkegaard C, Norlem N, Lauridsen UB, Bjorum N, Christiansen C (1975) Protirelin stimulation test and thyroid function during treatment of depression. Arch Gen Psychiatry 32: 1115–1118
Kroessler D (1985) Relative efficacy rates for therapies of delusiohnal depression. Convuls Ther 1: 173–182
Krog-Meyer I, Kirkegaard C, Kijne B, Lumholtz B, Smith E, Lykke-Olesen L, Bjorum N (1984) Prediction of relapse with the TRH test and prophylactic amitriptyline in 39 patients with endogenous depression. Am J Psychiatry 141: 945–948
Kukopulos A, Reginaldi D, Tondo L, Bernabei A, Caliari B (1977) Spontaneuous length of depression and response to ECT. Psycho) Med 7: 625–629
Landen M, Bjorling G, Agren H, Fahlen T (1998) A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression. J Clin Psychiatry 59: 664–668
Lauritzen L, Odgaard K, Clemmesen L, Lunde M, Ohrstrom J, Black C, Bech P (1996) Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand 94: 241–51
Linden M, Heimchen H, MackertA, MüIIer-Oerlinghausen B (1994) Structure and feasibility of a standardized stepwise drug treatment regimen ( SSTR) for depressed inpatients. Pharmacopsychiat 27: 51–53
Lipman RS, Uffner W, Schwalb N, Ravetz R, Lief B, Levy S, Levenberg D (1986) Dexamethasone suppression test as a predictor of response to electroconvulsive therpay. II: Six-month follow-up. ConvulsTher 2: 161–167
Magni G, Fisman M, Helmes E (1988) Clinical correlates of ECT-resistant depression in the elderly. J Clin Psychiatry 49: 405–407
Mandel MR (1975) Electroconvulsive therapy for chronic pain associated with depression. Am J Psychiatry 132: 632–636
Mandel MR, Welch CA, Mieske M (1977) Prediction of response to ECT in tricyclic-intolerant or tricyclic-resistant depressed patients. McLean Hosp J 2: 203–209
Markowitz), Brown R, Sweeney), Mann JJ (1987) Reduced length and cost of hospital stay for major depression in patients treated with ECT. Am J Psychiatry 144: 1025–1029
McCall WV (2001) Electroconvulsive therapy in the era of modern psychopharmacology. Int J Neuropsychopharmacol 4: 315–324
McCall WV, Reboussin DM, Weiner RD, et al (2000)Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Arch Gen Psychiatry 57: 438–444
McCall WV, Reid S, Rosenquist P, Foreman A, Kiesow-Webb N (1993) A reappraisal of the role of caffeine in ECT. Am J Psychiatry 50: 1543–1545
McDonald WM, McCall WV, Epstein CM (2002) Electroconvulsive therapy: sixty years of progress and a comparison with transcranial magnetic stimulation and vagal nerve stimulation. In: Davis KL, Charney D, Coyle JT, Nemeroff C (eds) Neuropsychopharmacology: the fifth generation of progress: an official publication of the American College of Neuropsychopharmacology, Williams Wilkins, Ort, pp 1097–1108
Medical Research Council (1965) Clinical trial of the treatment of depressive illness. BMJ 5439: 881–886
Möller HJ (1997) Therapieresistenz unter Antidepressiva: Definition, Epidemiologie and Risikofaktoren. In: Bauer M, Berghöfer A (Hrsg) Therapieresistente Depressionen. Springer, Berlin Heidelberg New York, S 3–15
Nemeroff CB, Evans DL (1984) Correlations between the dexamethasone suppression test in depressed patients and clinical response. Am J Psychiatry 141: 247–249
Nierenberg AA, Amsterdam JD (1990)Treatment-resistant depression: definition and treatment approaches. J Clin Psychiatry 51 [6, suppll: 39–47
Nierenberg AA, Dougherty D, Rosenbaum JF (1998) Dopaminergic agents and stimulants as antidepressant augmentation strategies. J Clin Psychiatry 59 [5, Suppl]: 60–63.
Nobler MS, Sackeim HA (1996) Prediction of response to electroconvulsive therapy: clinical and biological aspects. In: Goodnick P (ed) Electroconvulsive therapy: clinical and biological aspects. Predictors of treatment response in mood disorders. American Psychiatric Press, Washington DC, pp 177–198
Nobler MS, Sackeim HA (2000) Elektrokrampftherapie. In: Heimchen H, Henn F, Lauter H, Sartorius N (Hrsg) Psychiatrie der Gegenwart, Bd. 5: Schizophrene and affektive Störungen. Springer, Berlin Heidelberg New York, S 683–700
Nolen WA (1989) Tranlycypromine in depression resistant to cyclic antidepressants. Prog Neuro-Psychopharmacol Biol Psychiatr 13: 155–158
O’Leary DA, Lee AS (1996) Seven years prognosis in depression mortality and readmission risk in the Nottingham ECT cohort. Br J Psychiatry 169: 423–429
O’Leary DA, Gill D, Gregory S, et al (1995) Which depressed patients respond to ECT ? The Nottingham results. J Affect Disord 33: 245–250
Olfson M, Marcus S, Sackeim HA, Thompson J, Pincus HA (1998) Use of ECT for the ipatient treatment of recurrent major depression. Am J Psychiatry 155: 22–29
Pande AC, Krugler T, Haskett RF, Greden JF, Grunhaus LJ (1988) Predictors of response to electroconvulsive therapy in major depression. Biol Psychiatry 24: 91–93
PapakostasY, Fink M, Lee J, Irwin P, Johnson L (1981) Neuroendocrine measures in psychiatric patients: course and outcome with ECT. Psychiatry Res 4: 55–64
Paul SM, Extein I, Calil HM, Potter WZ, Chodoff P, Goodwin FK (1981) Use of ECT with treatment-resistant depressed patients at the National Institute of Mental Health. Am J Psychiatry 138: 486–489
Pearlman C (1987) High dose tranylcypromine in refractory depression [letter]. J Clin Psychiatry 48: 423–424
Perez V, Soler J, Puigdemont D, Alvarez E, Artigas F (1999) A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Arch Gen Psychiatry 56: 375–379
Perry P, Tsuang MT (1979) Treatment of unipolar depression following electroconvulsive therapy. J Affect Disord 1: 123–129
Post RM, UhdeTW, Rubinow DR, HugginsT (1987) Differential time course for antidepressant effects after sleep deprivation, ECT, and carbamazepine: clinical and theoretical impllications. Psychiat Res 22: 11–19
Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S, Greenberg R, Rifas SL, Sackeim HA (1996) Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 153: 985–992
Prudic J, Sackeim H (1990) Refractory depression and electroconvulsive therapy. In: Roose S, Glassman A (eds) Treatment of Refractory Depression. American Psychiatric Press, Washington, pp 109–128
Prudic J, Sackeim HA (1999) Electroconvulsive therapy and suicide risk. J Clin Psychiatry 60 [Suppl 2]: 104–110
Prudic J, Sackeim HA, Devanand DP (1990) Medication resistance and clinical response to electroconvulsive therapy. Psychiatric Res 31: 287–296
Prudic J, Sackeim HA, Devanand DP, Kiersky JE (1993) The efficacy of ECT in double depression. Depression 1: 38–44
Rabheru K, Persad E (1997) A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry 42: 476–484
Rodger CR, Scott Al, Whalley LJ (1994) Is there a delay in the onset of the antidepressant effect of electroconvulsive therapy? Br J Psychiatry 164: 106–109
Rush AJ, Crismon ML, Toprac MG, Trivedi MH, Rago WV, Shon SP, Altshuler KZ (1998) Consensus guidelines in the treatment of major depressive disorder. J Clin Psychiatry 59 [20, Suppl]: 73–84
Sackeim HA, Decina P, Kanzler M, Kerr B, Malitz S (1987) Effects of electrode placement on the efficacy of titrated low-dose ECT. Am J Psychiatry 144: 1449–1455
Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati Hm, Greenberg RM, Crowe RR, Cooper TB, Prudic J (2001) Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy. JAMA 285: 1299–1307
Sackeim HA, Prudic J, Devanand DP, Decina P, Kerr B, Malitz S (1990) The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 10: 96–104
Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Fitzsimons L, Moody BJ, Clark MA (2000) A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 57: 425–434
Sareen J, Enns MW, Guertin JE (2000)The impact of clinically diagnosed personality disorders on acute and one-year outcomes of electroconvulsive therapy. J ECT 16: 43–51
Schmauß M (1996) HochdosierteTranylcyprominbehandlung „therapieresistenter“ Depressionen. Nervenarzt 67: 390–393
Schweitzer I, Maguire KP, Gee AH, Tiller JWG, Biddle N, Davies B (1987) Prediction of outcome in depressed patients by weekly monitoring with the dexamethasone suppression test. Br J Psychiatry 151: 780–784
Seager CR, Bird RL (1962) Imipramine with electrical treatment in depression — a controlled trial. J Ment Sci 108: 704–707
Shapira B, Gorfine M, Lerer B (1995) A prospective study of lithium continuation therapy in depressed patients who have responded to electroconvulsive therapy. Convuls Ther 11: 80–85
Shiah IS, Yatham LN, Srisurapantont M, Lam RW, Tam EM, Zis AP (2000) Does the addition of pindolol accelerate the response to electroconvulsive therapy in patients with major depression? A double blind, placebo-controlled pilot study. J Clin Psychopharmacol 20: 373378
Simpson GM, Lee JH, Cuculic Z, Kellner R (1976) Two dosages of imipramine in hospitalized endogenous and neurotic depressives. Arch Gen Psychiatry 33: 1093–1102
Sobin C, Prudic J, Devanand DP, Nobler MS, Sackeim HA (1996) Who responds to electroconvulsive therapy? A comparison of effective and ineffective forms of treatment. Br J Psychiatry 169: 322–328
Sobin C, Sackeim HA, Prudic J, Devanand DP (1995) Predictors of retrograde amnesia following ECT. Am J Psychiatry 152: 995–1001
Solan WJ, Khan A, Avery D, Cohen S (1988) Psychotic and non-psychotic depression: comparison of response to ECT. J Clin Psychiatry 49: 97–99
Souery D, Lipp O, Massat I, Mendlewicz J (2001) The characterization and definition of treatment-resistant mood disorders. In: Amsterdam J, Hornig M, Nierenberg AA (eds) Treatment-resistant mood disorders. Cambridge University Press, Cambridge, pp 3–29
Spiker DG, Stein J, Rich CL (1985) Delusional depression and electroconvulsive therapy: one year later. Convuls Ther 1: 167–182
Stern RA, Nevels CT, Shelhorse ME, Prohaska ML, Mason GA, Prange AJ (1992) The use of T3 to enhance the effects of ECT. Clin Neuropharmacol 15 [Suppl]: 397A - 288A
Stevenson GH, Geoghegan JJ (1951) Prophylactic electroshock: a five-year study. Am J Psychiatry 107: 743–74
Thase ME, Kupfer DJ, Jarrett DB (1989) Treatment of imipramine-resistant recurrent depression. II. An open clinical trial of adjunctive L-triiodthyronine. J Clin Psychiatry 50: 385–388
Thase ME, Rush AJ (1995) Treatment-resistant depression. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, pp 10811097
Thase ME, Rush Ai (1997) When at first you don’t succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry 58 [Suppl] 13: 23–29
Thornton J, Mulsant B, Dealy R, Reynolds CF 3rd (1990) A retrospective study of maintenance electroconvulsive therapy in a university based psychiatric practice. Convuls Therapy 6: 121–129
Trivedi MH, Rush AJ, Crismon ML, Key T, KashnerTM, Biggs MM, Shores-Wilson K, Toprac MG, Carmody TJ, Witte B, Pigott, T, Shon SP (2000)TheTexas Medication Algorithm Project (TMAP): outcomes for persons with major depressive disorder [abstract]. 39th Annual Meeting of the American College of Neuropsychopharmacology; Dec. 10–14, 2000; San Juan, Puerto Rico
Tsutsui S, Yamazaki Y, Namba T, Tsushima M (1979) Combined therapy of T3 and antidepressants in depression. J Int Med Res 7: 138–146
Watt DC, Crammer JL, Elkes A (1972) Metabolism, anticholinergic effects, and therapeutic outcome of desmethylimipramine in depressive illness. Psycho) Med 2: 397–405
Wetterling T, Michels R, Dilling H (1998) Elektrokrampftherapie bei therapieresistenter Altersdepression. Nervenarzt 69: 617–621
Williams JH, O’Brien JT, Cullum S (1997)Time course of response to electroconvulsive therapy in elderly depressed subjects. Int J Geriatr Psychiatry 12: 563–566
Wilson IC, Vernon JT, Guin T, Sandifer MG (1962) A control led study of treatments of depression. J Neuropsychiatry 4: 331–332
Wolkowitz OM, ReusVl, KeeblerA, Nelson N, Friedland M, Brizendine L, Roberts E (1999) Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 156: 646–649.
Yerevanian BI, Olafsdottir H, Milanese E, Russotto J, Mallon P, Baciewicz G, Sagi E (1983) Normalization of the dexamethasone suppression test at discharge from hospital. J Affect Disord 5: 191–197
Zimmermann M, Coryell W, Pfohl B, Corenthal C, Stangl D (1986) ECT response in depressed patients with and without DSM-III personality disorder. Am J Psychiatry 143: 1030–1032
Zweifel JE, O’Brien WH (1997) A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 22: 189–212
Angst J (1985) Switch from depression to mania-a record study over decades between 1920 and 1982. Psychopathology 18: 140–154
APA (2002) The practice of electroconvulsive therapy: recommendations for treatment, training and privileging: a task force report of the american psychiatric association. American Psychiatric Press, Washington, DC
Black DW, Winokur G, Nasrallah A (1986) ECT in Unipolar and Bipolar Disorders: A Naturalistic Evaluation of 460 Patients. ConvulsTher 2: 231–237
Black DW, Winokur G, Nasrallah A (1987) Treatment of mania: a naturalistic study of electroconvulsive therapy versus lithium in 438 patients. J Clin Psychiatry 48: 132–139
Chanpattana W (2000) Combined ECT and clozapine in treatment-resistant mania. J ECT 16: 204–207
Ciapparelli A, Dell’Osso L, Tundo A, Pini S, Chiavacci MC, Di S, I, Cassano GB (2001) Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression. J Clin Psychiatry 62: 552–555
Clarke TB, Coffey CE, Hoffman GW Jr, Weiner RD (1989) Continuation Therapy for Depression Using Outpatient Electroconvulsive Therapy. ConvulsTher 5: 330–337
Daly JJ, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Roose SP, Sackeim HA (2001) ECT in bipolar and unipolar depression: differences in speed of response. Bipolar disorders 3: 95–104
Devanand DP, Polanco P, Cruz R, Shah S, Paykina N, Singh K, Majors L (2000) The efficacy of ECT in mixed affective states. J ECT 16: 32–37
Dilsaver SC, Chen YW, Swann AC, Shoaib AM, Tsai-Dilsaver Y, Krajewski KJ (1997) Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania. Psychiatry Res 73: 47–56
Folkerts H, Bender S, Erkwoh R, Klieser E, Klimke A (1996) Entwurf von DGPPN-Leitlinien zur Indikation and Durchführung der Elektrokrampftherapie ( EKT ). Nervenarzt 67: 509–514
Frey R, Schreinzer D, Heiden A, Kasper S (2001) Einsatz der Elektrokrampftherapie in der Psychiatrie. Nervenarzt 72: 661–676
Frye MA, Ketter TA, Leverich GS, Huggins T, Lantz C, Denicoff KD, Post RM (2000) The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry 61: 9–15
Gagne GG Jr, Furman MJ, Carpenter LL, Price LH (2000) Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry 157: 1960–1965
Geddes J (2003) Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 361: 799–808
Godemann F, Hellweg R (1997) 20 Jahre erfolglose Rezidivprophylaxe einer bipolar-affektiven Psychose. Nervenarzt 68: 582–585
Goldberg JF(2000) Treatment guidelines: current and future management of bipolar disorder. J Clin Psychiatry 61 [Suppli 13:12–18
Gruber NP, Dilsaver SC, Shoaib AM, Swann AC (2000) ECT in mixed affective states: a case series. J ECT 16: 183–188
Grunze H, Erfurth A, Schäfer M, Amann B, Meyendorf R (1999) Elektrokonvulsionstherapie in der Behandlung der schweren Manie. Nervenarzt 70: 662–667
Grunze H, Walden J, Dittmann S, Berger M, Bergmann A, Bräunig P, Dose M, Emrich HE, Gastpar M, Greil W, Möller H-J, Uebelhack R (2002) Psychopharmakotherapie Bipolarer Affektiver Erkrankungen. Nervenarzt 73: 4–17
Gupta S, Austin R, Devanand DP (1998) Lithium and maintenance electroconvulsive therapy. J ECT 14: 241–244
Hlastala SA, Frank E, Mallinger AG, Thase ME, Ritenour AM, Kupfer DJ (1997) Bipolar depression: an underestimated treatment challenge. Depress Anxiety 5: 73–83
Husain MM, Meyer DE, Muttakin MH, Weiner MF (1993) Maintenance ECT for treatment of recurrent mania. Am J Psychiatry 150: 985
Jaffe RL, Rives W, Dubin WR, Roemer RA, Siegel L (1991) Problems in Maintenance ECT in Bipolar Disorder: Replacement by Lithium and Anticonvulsants. Convuls Ther 7: 288–294
Jha AK, Stein GS, Fenwick P (1996) Negative interaction between lithium and electroconvulsive therapy—a case-control study. Br J Psychiatry 168: 241–243
Keck PE, McElroy SL, Tugrul KC, Bennett JA (1993) Valproate oral loading in the treatment of acute mania. J Clin Psychiatry 54: 305–308
Klapheke MM (1993) Combining ECT and Antipsychotic Agents: Benefits and Risks. Convuls Ther 9: 241–255
Kramer BA (1999) A naturalistic review of maintenance ECT at a university setting. J ECT 15: 262–269
Kupchik M, Spivak B, Mester R, Reznik I, Gonen N, Weizman A, Kotler M (2000) Combined electroconvulsive-clozapine therapy. Clin Neuropharmacol 23: 14–16
Kupka RW, Nolen WA, Altshuler LL, Denicoff KD, Frye MA, Leverich GS, Keck PE Jr, McElroy SL, Rush AJ, SuppesT, Post RM (2001)The Stanley Foundation Bipolar Network: 2. Preliminary summary of demographics, course of illness and response to novel treatments. Br J Psychiatry 178: 5177–5183
Lippmann SB (1994) Can elektroconvulsive therapy be given during lithium treatment. Lithium 5: 205–209
McCabe MS, Norris B (1977) ECT versus chlorpromazine in mania. Biol Psychiatry 12: 245–254
Miller MC (1995) ECT and mania. Am J Psychiatry 152: 654
Milstein V, Small JG, Klapper MH, Small IF, Miller MJ, Kellams JJ (1987) Uni-Versus Bilateral ECT in the Treatment of Mania. ConvulsTher 3: 1–9
Mishory A, Yaroslaysky Y, Bersudsky Y, Belmaker RH (2000) Phenytoin as an antimanic anticonvulsant: a controlled study. Am J Psychiatry 157: 463–465
Mukherjee S(1 989) Mechanisms oftheAntimanic Effectof ElectroconvulsiveTherapy. Convuls Ther 5:227–243
Mukherjee S(1 993) Combined ECT and Lithium Therapy. ConvulsTher 9:274–284
Mukherjee S, Sackeim HA, Lee C (1988) Unilateral ECT in the treatment of manic episodes. Convuls Ther 4: 74–80
Mukherjee S, Sackeim HA, Schnur DB (1994) Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. Am J Psychiatry 151: 169–176
Peet M (1994) Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 164: 549–550
Penney JF, Dinwiddie SH, Zorumski CF, Wetzel RD (1990) Concurrent and Close Temporal Administration of Lithium and ECT. ConvulsTher 6: 139–145
Rabheru K, Persad E (1997) A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry 42: 476–484
Rihmer Z, Kiss K (2002) Bipolar disorders and suicide risk. Clinical Approaches in Bipolar Disorders 1: 15–21
Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Fitzsimons L, Moody BJ, Clark J (2000) A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 57: 425–434
Sikdar S, Kulhara P, Avasthi A, Singh H (1994) Combined chlorpromazine and electroconvulsive therapy in mania. Br J Psychiatry 164: 806–810
Small JG, Kellams JJ, Milstein V, Small IF (1980) Complications with electroconvulsive treatment combined with lithium. Biol Psychiatry 15: 103–112
Small JG, Klapper MH, Kellams JJ, Miller MJ, Milstein V, Sharpley PH, Small IF (1988) Electroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiatry 45: 727–732
Small JG, Klapper MH, MilsteinV, Marhenke JD, Small IF (1996) Comparison of therapeutic modalities for mania. Psychopharmacol Bull 32: 623–627
Small JG, Small IF, MilsteinV, KellamsJJ, Klapper MH (1985) Manic symptoms: an indication for bilateral ECT. Biol Psychiatry 20: 125–134
Standish-Barry HM, Deacon V, Snaith RP (1985) The relationship of concurrent benzodiazepine administration to seizure duration in ECT. Acta Psychiatr Scand 71: 269–271
Strömgren LS (1988) Electroconvulsive therapy in Aarhus,Denmark, in 1984: its application in non-depressivedisorders. Convuls Ther 4: 306–313
Strömgren LS, Dahl J, Fjeldborg N, Thomsen A (1980) Factors influencing seizure duration and number of seizures applied in unilateral electroconvulsive therapy. Anaesthetics and benzodiazepines. Acta Psychiatr Scand 62: 158–165
Suppes T, Webb A, Paul B, Carmody T, Kraemer H, Rush Al (1999) Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 156: 1164–1169
Swoboda E, Conca A, Konig P, Waanders R, Hansen M (2001) Maintenance electroconvulsive therapy in affective and schizoaffective disorder. Neuropsychobiology 43: 23–28
Thomas J, Reddy B (1982)The treatment of mania. A retrospective evaluation of the effects of ECT, chlorpromazine, and lithium. J Affect Disord 4: 85–92
Tohen M (2002) Olanzapine vs placebo for relapse prevention in bipolar disorder. Data presented at the ACNP, Puerto Rico 7–10. 12. 2002
b.Tohen M, Marneros A, Bowden C, Calabrese J, Greil W, Koukopoulis A, Belmaker R, Jacobs TG, Robert MAS, Baker RW, Williamson D, Evans AR, Cassano GB (2002) Olanzapine versus lithium in relapse prevention in bipolar disorder: a randomized double-blind controlled 12-month clinical trial. Bipolar Disord 4[Suppl 11: 135
Vanelle JM, Loo H, Galinowski A, de Carvalho W, Bourdel MC, Brochier P, Bouvet O, Brochier T, Olie JP (1994) Maintenance ECT in intractable manic-depressive disorders. ConvulsTher 10: 195–205
Vieta E, Goikolea JM, Corbella B, Benabarre A, Reinares M, Martinez G, Fernandez A, Colom F, Martinez-Aran A, Torrent C (2001) Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. J Clin Psychiatry 62: 818–825
Vieta E, Reinares M, Corbella B, Benabarre A, Gilaberte I, Colom F, Martinez-Aran A, Gasto C, Tohen M (2001) Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder. J Clin Psychopharmacol 21: 469–473
Aboraya A, Schumacher J, Abdalla E, LePage J, McGhee M, Butcher D, Griffin H, Shanda M (2002) Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia. WV Med J 98: 63–65
Abraham KR, Kulhara P (1987)The efficacy of electroconvulsive therapy in the treatment of schizophrenia. Br J Psychiatry 151: 152–155
Abrams R (1994) Elektrokonvulsionstherapie, 2. Auflage. Lake Bluff; Somatics, Incorporated
Agel ink MW, Dammers S, Malessa R, Leonhardt M, Zitzelsberger A, Ullrich H, ZeitT (1998) Nutzen und Risiken der Elektrokrampfbehandlung ( EKT) bei älteren Patienten mit kardiovaskulären Risikofaktoren. Nervenarzt 69: 70–75
American Psychiatric Association (2001) The practice of ECT: Recommendations for Treatment, Training and Privileging. Am Psychiatric Assoc, Washington DC
Bailine SH, Rifkin A, Kayne E, Selzer JA, Vital-Herne J, Blieka M, Pollack S (2000) Comparison of bifrontal and bitemporal ECT for major depression. Am J Psychiatry 157: 121–123
Bara A (2000) Stellungnahme. Nervenarzt 7: 223–224
Batra A, Bartels M, Foerster K (1999) Zur Frage der Genehmigungspflicht von Elektrokrampftherapie im Rahmen einer Betreuung (§1904 BGB). Nervenarzt 70: 657–661
Belanoff JK, Flores BH, Kalezhan M, Sund B, Schatzberg AF (2001) Rapid reversal of psychotic depression using mifepristone. J Clin Psychopharmacol 21: 516–521
Bottlender R, Jager M, Hofschuster E, Dobmeier P, Moller HJ (2002) Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient. Pharmacopsychiatry 35: 119–121
Brandon S, Cowley P, McDonald C, Neville P, Palmer R, Wellstood-Eason S (1985) Leicester ECT trial-results in schizophrenia. BrJ Psychiatry 146: 177–183
Bräunig P, Krüger S, Shugar G (1999) Prävalenz und klinische Bedeutung katatoner Symptome bei Manien. Fortschr Neurol Psychiat 67: 306–317
Brüne M, Bräunig P (1999) Stabilität und Variabilität katatoner Symptome im Krankheitslängsschnitt. Nervenarzt 70: 26–30
Bush G, Fink M, Petrides G, Dowling F, Francis A (1996) Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 93: 137–143
Cardwell BA, Nakai B (1995) Seizure activity in combined Clozapin and ECT: a retrospective view. ConvulsTher 11: 110–113
Caroff SN, Mann SC, Campbell EC, Sullivan KA (2002) Movement disorders associated with atypical antipsychotic drugs. J Clin Psychiatry 63 [Suppl 4]: 12–19
Chanpattana W, Buppanharun W, Raksakietisak S, Vaughn McCall W, Somchai Chakrabhand ML (2000) Seizure threshold rise during electroconvulsive therapy in schizophrenic patients. Psychiatry Res 96: 31–40
Chanpattana W, Chakrabhand ML (2001) Factors influencing treatment frequency of continuation ECT in schizophrenia. J ECT 17 (3): 190–194
Chanpattana W, Chakrabhand ML, Buppanharun W, Sackeim HA (2000) Effects of stimulus intensity on the efficacy of bilateral ECT in schizophrenia: a preliminary study. Biol Psychiatry 48: 222–228
Chanpattana W, Chakrabhand ML, Kitaroonchai W, Choovanichvong S, PrasertsukY (1999) Effects of twice-versus thrice-weekly electroconvulsive therapy in schizophrenia. J Med Assoc Thai 82: 477–483
Chanpattana W, Chakrabhand ML, Kongsakon R, Techakasem P, Buppanharun W (1999) Short-term effect of combined ECT and neuroleptic therapy in treatment resistant schizophrenia.) ECT 15: 129–139
Charlton BG, Kavanau JL (2002) Delirium and psychotic symptoms-an integrative model. Med Hypotheses 58: 24–2 7
Childers R (1964) Comparison of four regimes in newly admitted female schizophrenics. Am J Psychiatry 120: 1010–1011
Cizaldo BC, Wheaton A (1995) Case study: ECT treatment of a young girl with catatonia. J Am Acad Child Adolesc Psychiatry 34: 332–335
Cohen D, Flament M, Taieb O, Thompson C, Basquin M (2000) Electroconvulsive therapy in adolescence. European Child Adolescence Psychiatry 9: 1–6
Cohen D, Taieb O, Flament M, Benoit N, Chevret S, Corcos M, Fossati P, Jeammet P, Allilaire J-F, Basquin M (2000) Absence of cognitive impairement at long-term follow-up in adolescents treated with ECT for severe mood disorder. Am J Psychiatry 157: 460–462
Conca A, Pycha R, Prapotnik M (2002) Elektrokonvulsionstherapie-Konsensus AG für spezielle biologische Verfahren der ÖGPP
Conley RR, Kelly DL (2001) Management of treatment resistance in schizophrenia. Biol Psychiatry 50: 898–911
Davis JM, Janicak PG, Sakkas P, Gilmore C, Wang Z (1991) Electroconvulsive Therapy in the Treatment of the Neuroleptic Malignant Syndrome. Convuls Ther 7: 111–120
Devanand DP, Dwork AJ, Hutchinson ER, Bolwig TG, Sackeim HA (1994) Does ECT alter brain structure? Am J Psychiatry 151: 957–970
Dinwiddie SH, Drevets WC, Smith DR (1988) Treatment of Phencyclidine-Associated Psychosis with ECT. Convuls Ther 4: 230–235
Dinwiddie SH, Drevets WC, Smith DR (1988) Treatment of Phencyclidine-Associated Psychosis with ECT. Convuls Ther 4: 230–235
Dodwell D, Goldberg D (1989) A study of factors associated with response to electroconvulsive therapy in patients with schizophrenic symptoms. Br J Psychiatry 1989 154: 635–639
Ende G, Braus DE, Walter S, Weber-Fahr W, Henn F (2000) The hippocampus in patients treated with electroconvulsive therapy. Arch Gen Psychiatry 57: 937–943
Fall PA, Ekman R, Granerus AK, Thorell LH, Walinder J (1995) ECT in Parkinson’s desease. Changes in motor symptoms, monoamine metabolites and neuropeptides. J Neural Transm Park Dis Dement Sect 10: 129–140
Fink M (1998) ECT and clozapine in schizophrenia [Editorial]. J ECT 14: 223–226
Fink M (2001) Catatonia: syndrome or schizophrenia subtype? Recognition and treatment. J Neural Transm 108: 637–644
Fink M (2001) Convulsive therapy: a review of the first 55 years. J Affect Disord 63: 1–15
Fink M, Taylor MA (2002) Catatonia: A Clinician’s Guide to Diagnosis, Treatment and Neurology. Cambridge University Press, Cambridge, UK
Fink M, Sackeim HA (1996) Convulsive therapy in schizophrenia? Schizophr Bull 22 (1): 27–39
Folkerts H (1995) Elektrokrampftherapie. Dt Ärztebl 92: A-358–364
Frankenburg FR, Supps T, McLean PE (1993) Combined Clozapine and electroconvulsive therapy. Convuls Ther 9: 176–180
Frey R, Schreinzer D, Heiden A, Kasper S (2001) Einsatz der Elektrokrampftherapie in der Psychiatrie. Nervenarzt 72: 661–676
Friedel RO (1986) The combined use of neuroleptics and ECT in drug resistant schizophrenic patients. Psychopharmacol Bull 22: 928–930
Gaebel W, Falkai P (1996) Entwurf von DGPPN-Leitlinien zur Indikation and Durchführung der Elektrokrampftherapie ( EKT ). Nervenarzt 67: 509–514
Ghaziuddin N, Laughrin D, Giordani B (2000) Cognitive side effects of electroconvulsive therapy in adolescents. J Child Adolesc Psychopharmacol 10: 269–276
Grunze H, Erfurth A, Schäfer M, Amann B, Meyendorf R (1999) Elektrokonvulsionsbehandlungstherapie in der Behandlung der schweren Manie. Nervenarzt 70: 662–667
Gujavarty K, Greenberg LB, Fink M (1987) Electroconvulsive Therapy and Neuroleptic Medication in Therapy-Resistant Positive-Symptom Psychosis. Convuls Ther 3: 185–195
Hafeiz HB (1987) Psychiatric manifestations of enteric fever. Acta Psychiatr Scand 75: 69–73
Heils A, Lesch KP (1997) Neuroleptic malignant syndrome and life threatening catatonia-two contrasting disease entities? Fortschr Neurol Psychiatr 65: 8–15
Hirose S, Ashby CR, Mills MJ (2001) Effectiveness of ECT combined with risperidone against aggression in schizophrenia. J ECT 17: 22–26
Ishihara K, Sasa M (1999) Mechanism underlying the therapeutic effects of electroconvulsive therapy ( ECT) on depression. Jpn J Pharmacol 80: 185–189
Janakiramaiah N, Channabasavanna SM, Murthy NS (1982) ECT/chlorpromazine combination versus chlorpromazine alone in acutely schizophrenic patients. Acta Psychiatr Scand 66: 464–470
Janicak PG, Davis JM, Gibbons RD, Ericksen S, Chang S, Gallagher P (1985) Efficacy of ECT: a meta-analysis. Am J Psychiatry 14: 297–302
Janowsky EC, Risch C, Janowsky DS (1981) Effects of anesthesia on patients taking psychotropic drugs. J Clin Psychopharmacol 1: 14–20
Juckel G, Mendlin A, Jacobs BL (1999) Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output: implications for electroconvulsive therapy and trans-cranial magnetic stimulation in depression. Neuropsychopharmacology 21: 391–398
Kales HC, Dequardo JR, Tandon R (1999) Combined electroconvulsive therapy and clozapine in treatment resistent schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 23: 547556
Katschnig H, Donat H, Fleischhacker WW, Meise U (2002) 4x8 Empfehlungen zur Behandlung von Schizophrenie. edition pro mente, Linz
Keck PE Jr, Caroff SN, McElroy SL (1995) Neuroleptic malignant syndrome and malignant hyperthermia: end of a controversy? J Neuropsychiatry Clin Neurosci 7: 135–144
Kellner CH (1999) Novel electrode placements: time to reassess (Editorial). J ECT 15: 115–117
Klapheke MM (1991) Clozapine, ECT, and schizoaffective disorder, bipolar type. Convuls Ther 7: 36–39
Klimke A, Klieser E (1991) [Effectiveness of neuro-electric therapy in drug resistant endogenous psychoses]. Fortschr Neurol Psychiatr 59: 53–59
König P, Glatter-Götz U (1990) Combined electroconvulsive and neuroleptic therapy in schizophrenia refractory to neuroleptics. Schizophr Res 3: 351–4
Krankenanstaltenrecht (2000) Herausgeber A. Radner, A.Haslinger, P. Reinberg, T. Radner. Rudolf Traum Verlag Linz 2000; 55. Lieferung 2001
Krueger RB, Sackeim HA (1995) Electroconvulsive therapy and schizophrenia. In: Hrisch S, Weinberger D (eds) Schizophrenia. Oxford, England. Blackwell, pp 503–545
Kupchik M, Spivak B, Mester R, Reznik I, Gonen N, Weizman A, Kotler M (2000) Combined electroconvulsive-clozapine therapy. Clin Neuropharmacol 23: 14–16
Landmark J, Joseph L, Merskey H (1987) Characteristics of schizophrenic patients and the outcome of fluphenazine and of electroconvulsive treatments. Can J Psychiatry 32: 425–428
Landy DA (1991) Combined use of clozapine and electroconvulsive therapy. Convuls Ther 7: 218–221
Lee JWY (1998) Serum iron in catatonia and neuroleptic malignant syndrome. Biol Psychiatry 44: 499–507
Letemendia FIJ, Delva NJ, Rodenburg M, Lawson JS, Inglis J, Waldron JJ, Lywood DW (1993) Therapeutic advantage of bifrontal electrode placement in ECT. Psychol Med 23: 349–360
Lisanby SH, Bazil CW, Resor SR, Nobler MS, Finck DA, Sackeim HA (2001) ECT in the treatment of status epi lepticus. J ECT 2001 17: 210–215
Llorca PM, Chereau I, Bayle FJ, Lancon C (2002) Tardive dyskinesias and antipsychotics: a review. Eur Psychiatry 17: 129–138
Mac DS, Pardo MP (1983) Systemic lupus erythematosus and catatonia: a case report. J Clin Psychiatry 44: 155–156
Malur C, Francis A (2001) Emergence of catatonia during ECT. J ECT 17: 201–204
Mann SC, Auriacombe M, Macfadden W, Caroff SN, Cabrina Campbell E, Tignol J (2001) [Lethal catatonia: clinical aspects and therapeutic intervention. A review of the literature] Encephale 27: 213–216
Mann SC, Caroff SN, Bleier HR (1986) Lethal catatonia. Am J Psychiatry 143: 1374–1381
Masiar SJ, Johns CA (1991) ECT following clozapine. Br J Psychiatry 158: 135–136
May PRA (1968) Treatment of schizophrenia: A comparative study of five treatment methods. New York, Science House
McIntyre R, McCann SM, Kennedy SH (2001) Antipsychotic metabolic effects: weight gain, diabetes mellitus and lipid abnormalities. Can J Psychiatry 46: 273–281
Meduna Li (1935) Die Konvulsiontherapie der Schizophrenie. Psychr Neurol Wochenschr 37: 317–319
Miller L (1994) Use of electroconvulsive therapy during pregnancy. Hosp Commun Psychiatry 45: 444–450
Milstein V, Small JG, Miller MJ, Sharpley PH, Small IF (1990) Mechanisms of action of ECT: schizophrenia and schizoaffective disorder. Biol Psychiatry 27 (12): 1282–1292
Mukherjee S, DebsikdarV (1994) Absence of neuroleptic-induced parkinsonism in psychotic patients receiving adjunctive electroconvulsive therapy. Convuls Ther 10: 53–58
Nedopil N (1993) Die medikamentöse Versorgung als Heilbehandlung gemäß §1904 BGB. FamRZ 1: 24–27
Neubauer H (1993) Kriterien für die Beurteilung der Einwilligungsfähigkeit bei psychisch Kranken. Psychiat Prax 20: 166–171
Newman ME, Gur E, Shapira B, Lerer B (1998) Neurochemical mechanisms of action of ECS: evidence from in vivo studies. J ECT 14: 153–171
Nisijima K, Ishiguro T (1999) Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases. J ECT 15: 158–163
Nobler MS, Sackeim H (1993) Augmentation strategies in electroconvulsive therapy: a synthesis. Convuls Ther 9: 331–335
Pataki J, Zervas IM, Jandorf L (1992) Catatonia in a university inpatient service (1985–1990). Convuls Ther 8: 163–173
Pridmore S, Pollard C (1996) Electroconvulsive therapy in Parkinson’s disease: 30 month follow up. J Neurol Neurosurg Psychiatry 60: 693
Richter S (1994) Zur Anwendbarkeit der §§ 1904 BGB, 69d FGG bei Elektrokrampfbehandlungen psychisch Kranker. FamRZ 18: 1204–1205
Ries RK, Wilson L, Bokan JA, Chiles JA (1981) ECT in medication resistant schizoaffective disorder. Compr Psychiatry 22: 167–73
Rosenquist KJ, Walker SS, Ghaemi SN (2002) Tardive dyskinesia and Ziprasione. Am J Psychiatry 159: 1436
Royal College of Psychiatrists (1998) ECT.-1995: Second Report of the Royal College of Psychiatrists,Special Committee on ECT. I. Freeman, Chris II. Dorchetser: Henry Ling Ltd, Dorset Press; reprinted in 1998
Royal College of Psychiatrists (1989) Freeman CP, Crammer JL, Deakin JWF, McClelland R, Mann SA, Pippard J (eds) The practical administration of electroconvulsive therapy (ECT). London: Gaskell
Sachdev P, Mason C, Hadzi-Pavlovic D (1997) Case-control study of neuroleptic malignant syndrome. Am J Psychiatry 154: 1156–1158
Sackeim HA (1999)The anticonvulsant hypothesis of the mechanisms of action of ECT: current status.] ECT 15: 5–26
Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ, McElhiney MC, Coleman EA, Settembrino JM (1993) Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 328: 839–846
Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisnaby SH, Peyser S, Fitzsimons L, Moody BJ, Clark J (2000) A prospective, randomised, double-blind comparison of bilateral and right unilateral ECT at different stimulus intensities. Arch Gen Psychiatry 57: 425–434
Sajatovic M, Meltzer HY (1993) The Effect of Short-Term Electroconvulsive Treatment Plus Neuroleptics in Treatment-Resistant Schizophrenia and Schizoaffective Disorder. Convuls Ther 9: 167–175
Sakel M (1935) Neue Behandlungsmethoden der Schizophrenie. Perthes. Wien, Leipzig
Sauer H, Lauter H (1987) Elektrokrampftherapie. Nervenarzt 58: 201–209
Scheftner WA, Shulman RB (1992)Treatment Choice in Neuroleptic Malignant Syndrome. ConvulsTher 8: 267–279
Schneeweiß B, Zinkler M (2000) Zur Frage der Genehmigungspflicht von Elektrokrampftherapie im Rahmen einer Betreuung (§1904 BGB): Anmerkungen. Nervenarzt 71: 222–223
Schuld A, Kuhn M, Haack M, Kraus T, Hinze-Selch D, Lechner C, PollmacherT (2000) A comparison of the effect of clozapine and olanzapine on the EEG in patients with schizophrenia. Pharmacopsychiatry 33: 109–111
Silva RR, Munoz DM, Alpert M, Perlmutter IR, Diaz J (1999) Neuroleptic malignant syndrome in children and adolescents. J Am Acad Child Adolesc Psychiatry 38: 187–194
Small JG (1985) Efficacy of Electroconvulsive Therapy in Schizophrenia, Mania, and other Disorders. I. Schizophrenia. ConvulsTher 1: 263–270
Smith K, Surphlis WR; Gynther MD, Shimkunas AM (1967) ECT chlorpromazine and chlorpromazine compared in the treatment of schizophrenia. J Nery Ment Disease 144: 284–290
Smith S, Lindefors N, Hurd Y, Sharp T (1995) Electroconvulsive shock increases dopamine D1 and D2 receptor mRNA in the nucleus accumbens of the rat. Psychopharmacology (Berl) 120: 333–40
Spiess-Kiefer C, Hippius H (1986) Neuroleptisches Syndrom and Maligne Hyperthermie: ein Vergleich. Fortschr Neurol Psychiatr 54: 158–170
Strömgren LS (1997) ECT in acute delirium and related clinical states. ConvulsTher 13: 10–17
Tarsy D, Baldessarini RJ, Tarazi Fl (2002) Effects of newer antipsychotics on extrapyramidal function. CNS Drugs 16: 23–45
Taylor PJ, Fleminger JJ (1980) ECT for schizophrenia. Lancet 1: 1380–1382
Tharyan P, Adams CE (2002) Electroconvulsive therapy for schizophrenia (Cochrane Review). Cochrane Database Syst Rev 2: CD000076
Trollor JN, Sachdev PS (1999) Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases. Aust N Z J Psychiatry 33: 650–659
Tsuang MT, Dempsey GM, Fleming JA (1997) Can ECT prevent premature death and suicide in,schizoaffective’ patients? J Affect Disord 1: 167–171
Unterbringungsgesetz Hersausgeber G. Hopf, G. Aigner. Wien 1993 Manzsche Verlags-und Universitätsbuchhandlung. Sonderausgabe 82
Weller EB, Weller RA (2000) Treatment options in the management of adolescent depression. J Affect Disord 61 [Suppl 11: 23–28
World Health Organization (1979) Schizophrenia. An international Follow up Study. New York, Wiley
Yoshida K, Higuchi H, Kamata M, Yoshimoto M, Shimizu T, HishikawaY (1998) Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats. Prog Neuropsychopharmacol Biol Psychiatry 22 (2): 435–444
Zis AP, Nomikos GG, Damsma G, Fibiger HC (1991) In vivo neurochemical effects of electroconvulsive shock studied by microdialysis in rat striatum. Psychopharmacology 103: 343–350
Abrams R (1997) ElectroconvulsiveTherapy, 3rd edn. Oxford University Press, NewYork, 382
Abrams R (2000)….and there’s no proof of lasting brain damage. Nature 403: 826
American Psychiatric Association (1999) Treatment guidelines for the treatment of patients with Schizophrenia. Am J Psychiatry 154: 1–63
Andrade C, Kurinji S (2002) Continuation and maintenance ECT: a review of recent research. J ECT 18 (3): 149–158
Andrade C (2001) Electroconvulsive therapy for Schizophrenia. In: Mandal MK, Nizamie H (eds) Schizophrenia. Oxford University Press
Asnis F, Gabriel AN (1976)ECT as Maintenance therapy in schizophrenia. Am J Psychiatry 133: 858–859
Azorin JM, Spiegel R, Remington G, Vanelle JM, Pere JJ, Giuguere M, Bourdeix I (2001) A double-blind comparative study of clozapine and risperidone in the management of severee chronic schizophrenia. 158: 1305–13
Barnes RC, Hussein A, Anderson DN, et al (1997) Nainetenance ECT and cognitive function. Br J Psychiatry 170: 285–7
Blake LM, Marks RC, Luchins DJ (1992) Reversible neurologic symtpoms with clozapine and lithium—letter. J Clin Psychopharmacol 12: 297–299
Carman JS, Bigelow LB, Wyatt RJ (1981) Lithium combined with neuroleptics in chronic schizophrenic and schizoaffective patients. J Clin Psychiatry 42: 124–128
Carpenter WT Jr, Conley RR, Buchanan RW, Breier A, Tamminga CA (1995) Patient response and resource management: Another view of clozapine treatment of schizophrenia. Am J Psychiatry 152: 827–832
Centorrino F, Baldessarini RJ, Frankenburg FR, Kando JC, Volpicelli SA, Flood J G (1994) Serum levels of clozapine and norclozapine and its major metabolites: Effects of cotratment with fluoxetine or valporate. Am J Psychiatry 153: 820–822
Chanpattana W, Chakrabhand MLS, Kongsakon R, et al (1999) Short-term effect of combined ECT and neuroleptic therapy in treatment resistant schizophrenia. J ECT 15: 129–139
Chanpattana W, Kramer BA (2003) Acute and maintenance ECT with flupentixol in refractory schizophrenia: sustained improvements in psychopathology, quality of life, and social outcomes. Schizophrenia Research (in press)
Chanpattana W, Somchai Chakrabhand ML, Buppanharun W, Sackeim HA (2000) Effects of Stimulus Intensity on the Efficacy of Bilateral ECT in Schizophrenia: A Preliminary Study. Biol Psychiatry 48: 222–228
Chanpattana W, Somchai Chakrabhand ML, Sackheim HA, Kitaroonchai W, Kongsakon R, Techakasem P, Buppanharun W, TuntirungseeY, Kirdcharoen N (1999) Continuation ECT in Treatment-resistant Schizoprenia: a controlled Study. J ECT 15 (3): 178–192
Chanpattana W, Somchai Chakrabhand ML (2001) Combined ECT and neuroleptic therapy in treatment-refractory schizophrenia: prediction of outcome. Psychiatry Research 105: 107115
Childers R, Therien R (1961) Comparison of the effectiveness of trifluoperazine and chlorpromazine in schizophrenia. Am J Psychiatry 118: 552–554
Chong SA, Remington G (2000) Clozapine augmentation: Safety and Efficacy. Schizophr Bull 26: 421–440
Christoson, GW, Kirch DG, Wyatt RJ (1991) When symptoms persist: Choosing among alternative treatments for schizophrenia. Schizophrenia Bulletin 17 (2): 217–245
Coffey CE, Weiner RD (1990) Electroconvulsive therapy: an update. Hosp Community Psychiatry 41 (5): 515–521
Cohen D, Taieb O, Flaument M, Benoit N, Chevret S, Corcis M, Fossati P, Jeammet P, Alliaire J F, Basquin M (2000) Absence of Cognitive Impairment at Long-Term Follow-Up in Adolescents Treated With ECT for Severe Mood Disorder. Am J Psychiatry 157 (3): 460–462
Conley RR,Tamminga CA, Bartko JJ, Richardson C, Peszke M, Lingle J, et al (1999)Treatmentresistant schizophrenic patients respond to clozapine after olanzapine non-response. Biol Psychiatry 46: 73–77
Datto CJ, Levy S, Miller DS, et al (2001) Impact of maintenance ECT on concentration and memory. J ECT 17: 170–174
Datto CJ (2000) Side effects of electroconvulsive therapy. Depression and Anxiety 12: 130134
Davis JM, Casper R (1977) Antipsychotic drugs: Clinical pharmacology and therapeutic use. Drugs 14: 260–282
Devanand DP, Dwork At Hutchinson ER, et al (1994) Does ECT alter brain structure? Am J Psychiatry 151: 957–70
Dodwel I D, Goldberg D (1989) A study of factors associated with response to electroconvulsive therapy in patients with schizophrenic symptoms. Br J Psychiatry 154: 635–639
Eranti SV, McLoughlin DM (2003) ElectroconvulsiveTherapy — state of the art. Br J Psychiatry 182: 8–9
Essock SM, Hargreaves WA, Dohm FA, Goethe J, Carver L, Hipshman L (1996) Clozapine Eligibility among state hospital patients. Schizophrenia Bulletin 22: 15–25
Faisal I, Lindenmeyer JP, Tatintor Z, Cancro R (1997) Clozapine-benzodiazepine interactions. J Clin Psychiatry 58 (12): 547–548
Fink M, Abrams R, Bailine S, et al (1996) Ambulatory electroconvulsive therapy: report of a task force of the Association for Convulsive Therapy. Convuls Ther 12: 42–55
Fink M, Sackeim HA (1996) Convulsive Therapy in Schizophrenia? Schiz Bull 22 (1): 27–39
Fink M (1990) Clozapine and electroconvulsive therapy. Arch Gen Psychiatry 47: 290–291
Fink M (1991) Impact of the antipsychiatry movement on the revival of electroconvulsive therapy in the United States. Psychiatr Clin North Am 14 (4): 793–801
Fleischhacker WW (1999) Clozapine: a comparison with other novel antipsychotics. J Clin Psychiatry 60 [Suppl 12]: 30–34
Friedel RO (1986)The combined use of neuroleptics and ECT in drug resistant schizophrenic patients. Psychopharmacol Bull 22: 928–930
Geddes J, Freemantle N, Harrison P, Bebbington P (2000) Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ (2); 321 (7273): 1371–1376
Gelenberg AL (1989) Clozapine induced agranulocytosis and seiures. Biol Ther Psychiatr 12: P2–3
Gujavarty K, Greenberg L, Fink M (1987) Electroconvulsive therapy and neuroleptic medication in therapy-resistant positive-symptom psychosis. Convuls Ther 3: 185–95
Guy W (1976) ECDEU Assessment manual for psychopharmacology. US Dept of Health and Human Services publication. ADM 76 (338): 524–535
Hay AG, Scott AIF (1994) Electroconvulsive therapy and brain damage. Br J Psychiatry 165: 120–121
Hegarty JD, Badessarini RJ, Tohen M, Waternaux C, Oepen G (1994) One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry 151: 1409–1416
Hoffler J, Trenckmann U, Graf von der Schulenburg JM (2000) Health economics and evaluation of schizophrenic psychosis in Germany. Fortschr Neurol Psychiatr 68 [Suppl 11: 7–12
Jackson CW, Markowitz JS, Brewerton TD (1995) Delirium associated with clozapine and benzodieazepine combinations. Ann Clin Psychiatry 7 (3): 139–141
Kales HC, Dequardo JR, Tandon R (1999) Combined electroconvulsive therapy and clozapine in treatment resistant schizophrenia. Prog. Neuro-Psychopharmacol Biol Psychiat 23: 547–556
Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45: 789–796
Kane JM, Honigfeld G, Singer J, Meltzer HY and the Clozaril Collaborative Study Group (1988) Clozapine for the treatemt-resistant schizophrenic: A double-blind comparison with chlorpromazine. Archives of General Psychiatry 45: 789–796
Kane JM, Marder SR (1993) Psychopharmacologic treatment of Schizophrenia. Schiz Bull 19: 287–302
Kane JM (1992) Clinical efficacy of clozapine in treamtent refractory schizophrenia: an overview. Br J Psychiatry 160 [Suppl 17]: 41–45
Karliner W, Wertheim HK (1965) Maintenance convulsive treatments. Am J Psychiatry 212: 1113–1115
Keks NA, Altson K, Hope J, Krapivensky N, Culhane C, Tanaghow A, Doherty P, Bootle A (1999) Use of antipsychotics and adjunctive medications by an inner urban community psychiatric service. Austr NZ J Psychiatry 33 (6): 896–901
Kellner CH, Burns CM, Bernstein HJ, et al (1991) Electorde placement in maintenance electroconvulsive therapy. Convuls Ther 7: 61–62
Klein HE, Rüther E (1983) Klinisch bedeutsame Wechselwirkungen der Psychopharmaka. In: Langer G, Heimann H (Hrsg) Psychopharmaka. Grundlagen undTherapie. Springer, Wien New York, 617–635
Konig P, Glatter-Gotz U (1990) Combined electroconvulsive and neuroleptic therapy in schizophrenia refractory to neuroleptics. Schizophrenia Res 3: 351–354
Krueger RB, Sackeim HA (1995) Electroconvulsive therapy and schizophrenia. In: Hirsch S, Weinberger D (eds) Schizophrenia. Blackwell, Oxford, England, pp 503–545
Krueger, RB, Sackheim HA (1995) Electroconvulsive therapy of schizophrenia. In: Hirsch S, Weinberger D (eds) Schizophrenia. Oxford University Press, Oxford, pp 503–545
Kupchik M, Spivak B, Mester R, Reznik I, Gonen N, Weizman A, Kotler M (2000) Combined Electroconvulsive-Clozapine Therapy. Clinical Neuropharmacology 23 (1): 14–16 )
Lewis AB (1982) ECT in drug-refractory schizophrenics. Hill J Clin Psychiatry 4: 141–54
Marder SR, Ames D, Wirshing WC, Van Putten T (1993) Schizoprenia. Psychiatr Clin N Am 16: 567–87
May PR, Tuma AH, Dixon WJ, Yale C, Thiele DA, Kraude WH (1981) Schizophrenia: A fol low-up study of the results of five forms of treatment. Archives of General Psychiatry 38: 776–784
Mc Glashan TH (1988) A selective review of recent North American long term follow up studies of schizophrania. Schizophrenia bulletin 14: 515–542
McCall WV, Reboussin DM, Weiner RD, Sackeim HA (2000)Titrated moderately supratreshold vs fixed high-dose right unilateral electroconvusliver therapy: acute antidepressant and cognitive effects. Arch Gen Psychiatry 57(5): 438–44
Meduna L (1939) Die Konvulsionstherapie der Schizophrenie: Rückblick and Ausblick. Psychiatrisch-neurologische Wochenschrift 41: 165–169
Meduna L (1985) Autobiography of LO. J. Meduna Convuls Ther 1: 43–57, 121–135
Meltzer HY, Bastani B, Kwon KY, Ramierz LF, Burnett S, Shape J (1989) A prospective study of clozapine in treatment-resistant schizophrenia patients. Psychopharmacology 99: 568–72
Meltzer HY (1992) Treatment of the Neuroleptic-Nonresponsive Schizophrenic Patient. Schiz Bull 18 (3): 515–42
Miller AL, Chiles JA, Chiles JK, Crimson ML, Rush JA, Shon SP (1999) The Texas Medication Algorithm Project ( TMAP) schizophrenia algorithms. J Clin Psychiatry 60: 649–657
Milstein V, Small JG, Miller JG, et al (1990) Mechanisms of action of ECT: schizophrenia and schizoaffective disorder. Biol Psychiatry 27: 1282–1292
Möller HJ (1996)Therapie mit Neuroleptika. In: Möller HJ, Schmauß M (Hrsg) Arzneimitteltherapie in der Psychiatrie. Wiss. Verl.-Ges., Stuttgart, 147–224
Moore NP (1943) The maintenance treatment of chronic psychosis by electrically induced convulsions. Journal of Mental Sciences 89: 257–259
Morera AL, Barriero P, Cano-Munoz JL (1999) Risperidone and clozapine combination for the treatment of refractory schizophrenia. Acta Psychiatr Scand 99 (4): 305–306
Müller U, Klimke A, Jänner M, Gaebel W (1998) Die Elektrokrampftherapie in psychiatrischen Kliniken der Bundesrepublik Deutschland 1995. Nervenarzt 69: 15–26
Naber D, Holzbach R, Perro C, Hippius H (1992) Clinical management of clozapine patients in relation to efficacy and side effects. Br J Psychiatry 160 [Suppl 171: 54–59
Overall JE, Gorham DE (1961) The brief psychiatric rating scale. Psycho) reports 10: 799–812
Peusekens J (1998) Good medical practice in antipsychotic pharmacotherapy. Int Clin Psychopharmacol 13 [Suppl 3]: 35–41
Philpot M, Treloar A, Gormley N, Gustafson L (2002) Barriers to the use of electroconvulsive therapy in the elderly: A European Survey. Eur Psychiatry 17: 41–5
Rabheru K, Persad E (1997) A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry 42 (5): 476–84
Rahman A (1968) A review of treatment of 176 schizophrenic patients in the mental hospital Pabna Br J Psychiatry 114: 775–7
Royal College of Psychiatrists (1995) The ECT Handbook. The Second Report of the Royal College of Psychiatrist’s Special Committee on ECT (Council Report CR 39 ). London: Royal College of Psychiatrists
Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ, et al (1993) Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 328: 839–847
Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Fitzsimons L, Moody BJ, ClarkJ (2000) A prospective, randomized, double-blind comparison of bilateral and right unilateral ECT at different stimulus intensities. Arch Gen Psychiatr 57 (5): 425–34
Sackeim HA (1994) Central issues regarding the mechanisms of action of electroconvulsive therapy: directions for future research. Psychopharmacol Bull 30: 281–308
Sajatovic M, Meltzer HY (1993) The effect of short-term electroconvulsive treatment plus neuroleptics in treatment-resistant schizophrenia and schizoaffective disorder. ConvulsTher 9: 167–75
Salzman C (1980) The use of ECT in the treatment of schizophrenia. Am J Psychiatry 137: 1032–41
ScottA (1995) Continuation ECT (Maintenance ECT). In: Freeman CP (ed)The ECT Handbook. The Second Report of the Royal College of Psychiatrists’ Special Committee on ECT. London: Royal College of Psychiatrists, 72
Scott Al, Weeks DJ, McDonald CF (1991) Continuation electroconvulsive therapy: preliminary guidelines and an illustrative case report. Br J Psychiatry 159: 867–70
Shiloh R, Zemishlany Z, Aizenberg D, Radwan M, Schwartz B, Dorfman-Etrog P, et al (1997) Sulpiride augmentation in people with schizophrenia partially responsive to clozapine: A double-blind, placebo-controlled study. Br J Psychiatry 171: 569–573
Smith K, Surphlis WRP, Gynther MD, Shimkunas A (1967) ECT-chlorpromazine and chlorpormazine compared in the treatment of schizophrenia. J Nery Ment Dis 144: 284–290
Smith TE, Docherty JP (1998) Standards of care and clinical algorithms for treating schizophrenia. Psychiatr Clin North Am 21: 203–220
Stahl SM (1999) Antipsychotic polypharmacy, Part 1: Therapeutic option or dirty little secret? J Clin Psychiatry 60 (7): 425–6
Stahl SM (1999) Antipsychotic polypharmacy, Part 2: tips on use and misuse. J Clin Psychiatry 60 (8): 506–7
Stevenson GH, Geoghegan JJ (1951) Prophylactic Electroshock. Am J Psychiatry 107: 743748
Tharyan P, Adams CE (2002) Electroconvulsive therapy for schizophrenia. Chochrane Database Syst Rev 2: CD000076
The Practice of ECT (1990) Recommendations for Practice, Training, and Privileging. Task Force Report on ECT. American Psychiatric Press, Washington, DC
Thompson JW, Weiner RD, Myers CP (1994) Use of ECT in the United States in 1975, 1980, and 1986. Am J Psychiatr 151: 1657–1661
Treatment of Schizophrenia (1999) The expert consensus guideline series. JClin Psych iatr60 [Suppl 1 1]: 3–80.
Aarsland D, Larsen P, Waage O (1997) Maintenance electroconvulsive therapy in Parkinson’s disease. ConvulsTher 13: 274–277
Abrams R (1990) ECT as prophylactic treatment for bipolar disorder. Am J Psychiatry 147: 373–374
Abrams R (1997) Electroconvulsive therapy. 3rd edn. Oxford University Press, New York, 191
Alexopoulos Gs, Young RC, Abrams RC (1989) ECT in the high-risk geriatric patient. Convuls Ther 8: 75–87
American Psychiatric Association Task Force on Electroconvulsive Therapy (1990)The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging. APA Press, Washington DC
Andrade C, Kurinji S (2002) Continuation and maintenance ECT: a review of recent research. J ECT 18: 149–158
Angst J, Angst K, Baruffol I, Meinherz-Surbeck R (1992) ECT-imduced and drug-induced hypomania. ConvulsTher 8: 179–185
Aronson TA, Shukla S, HoffA (1987) Continuation therapy of ECT for delusional depression: a naturalistic study of prophylaptic treatments and relapse. ConvulsTher 3: 251–259
Association for Convulsive Therapy (1996). Ambulatory electroconvulsive therapy: report of a task force of the Association for Convulsive Therapy. ConvulsTher 12: 41–55
Barnes RC, Hussein A, Anderson DN, Powell D (1997) Maintenance electroconvulsive therapy and cognitive function. Br J Psychiatry 170: 285–287
Beale MD, Bernstein HJ, Kellner CH (1996) Maintenance electroconvulsive therapy for geriatric depression: a one-year follow-up. Clin Gerontologist 16: 86–90
Benbow SM (1991) ECT in late life. Int J Geriatric Psychiatry 6: 401–406
Bonds C, Frye MA, Coudreaut MF (1998) Cost reduction with maintenance ECT in refractory bipolar disorder. J ECT 14: 36–41
Burke WJ, Rubin EH, Zorumski CF, Wetzel RD (1987) The safety of ECT in geriatric psychiatry. J Am Geriatr Soc 35: 516–521
Casey DA, Davis MH (1994) Obsessive-compulsive disorder responsive to electroconvulsive therapy in an elderly woman. South Med J 87: 862–864
Cattan RA, Barry PP, Mead G, Reefe WE, Gay A, Silverman M (1990) Electroconvulsive therapy in octogenarians. J Am Geriatr Soc 38: 753–758
Chanpattana W, Chakrabhand MLS, Sackeim HA, Kitaroonchai W, Kongsakon R, Techakasem P, Buppanharun W, TuntirungseeY, Kirdcharoen N (1999) Continuation ECT in treatment-resistant schizophrenia: a controlled study. J ECT 15: 129–139
Clarke TB, Cofey CE, Hoffman GW, Weiner RD (1989) Continuation therapy for depression using outpatient electroconvulsive therapy. ConvulsTher 5: 330–337
Coppen A, Abouh-Saleh MT, Milln P (1981) Lithium continuation therapy following electroconvulsive therapy. Br J Psychiatry 139: 284–287
Datto CJ, Levy S, Miller DS, Katz IR (2001) Impact of maintenance ECT on concentration and memory. J ECT 17: 170–174
Decina P, Guthrie EB, Sackeim HA, Kahn D, Malitz S (1987) Continuation ECT in the management of relapses of major affective episodes. Acta Psychiatr Scand 75: 559–562
Douyon R, Serby M, Klutchko B, Rotrosen J (1989) ECT and Parkinson’s disease revisted: a „natural istic“ study. Am J Psychiatry 146: 1451–1455
Dubin WR, Jaffe R, Roemer R, Siegel L, Shoyer B,Venditti ML (1992)The efficacy and safety of maintenance ECT in geriatric patients. J Am Geriatr 40: 706–709
Fall PA, Granerus AK (1999) Maintenance ECT in Parkinson’s disease. J Neural Transm 106: 737–741
Fink M (1987) Maintenance ECT and affective disorder. ConvulsTher 3: 249–250
Fink M (1991) ECT in long-term follow-up of BPD. Biol Psychiatry 30: 1172
Fox HA (2001) Extended continuation and maintenance ECT for long-lasting episodes of major depression. J ECT 17: 60–64
Francis A, Fochtmann L (1993) Sustained down regulation of cortical beta-adrenergic receptor density with maintenance ECS. ConvulsTher 9: 185–1991
Friedman J, Gordon N (1992) Electroconvulsive Therapy in Parkinson’s Disease: A Report on Five Cases. ConvulsTher 8: 204–210
Husain MM, Meyer DE, Muttakin MH, Weiner MF (1993) Maintenance ECT for treatment of recurrent mania. Am J Psychiatry 150: 985
Gagne GG, Furman MJ, Carpenter LL, Price LH (2000) Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry 157: 1960–1965
Gerbaldo H, Müller-Siecheneder F (1996) Significance of primary negative symptoms in schizophrenic and other psychiatric patients. Fortschr Neurol Psychiatr 64: 221–227
Grunze H, Erfurth A, Schäfer M, Amann B, Meyendorf R (1999) Electroconvulsive therapy in the treatment of severe mania. Case report and a state-of-art review. Nervenarzt 70: 662–667
Gupta S, Austin R, Devanand DP (1998) Lithium and maintenance electroconvulsive therapy. J ECT 14 (4): 241–244
Imlah NW, Ryan E, Harrington JA (1965) The influence of antidepressant drugs on the response to electroconvulsive therapy and on subsequent relapse rates. Neuropsychopharmacology 4: 438–442
Jaffe R, Dubin W, Shoyer B, Roemer R, Sharon D, Lipschütz L (1990) Outpatient electroconvulsive therapy: efficacy and safety. ConvulsTher 6: 231–238
Jaffe RL, Rives W, Dubin WR, Roemer RA, Siegel L (1991) Problems in maintenance ECT in bipolar disorder: replacement by lithium and anticonvulsants. ConvulsTher 7: 288–294
Karliner W, Wehrheim HK (1965) Maintenance convulsive treatments. Am J Psychiatry 121: 1113–1115
Kellner CH, Burns CM, Bernstein HJ, Monroe RR (1991) Electrode placement in maintenance electroconvulsive therapy. ConvulsTher 7: 61–62
Kellner CH, Pritchett JT, Beale MD, Coffey CE (1997) Handbook of ECT. American Psychiatric Press Inc, Washington DC
Kramer BA (1987) Maintenance ECT: a survey of practice (1986). ConvulsTher 3: 260–268
Kramer BA (1999) A naturalistic review of maintenance ECT at a university setting. J ECT 15 (4): 262–269
Lippmann SB, Tao CA (1993) Electroconvulsive therapy and lithium: safe and effective treatment. ConvulsTher 9: 54–57
Loo H, Galinowski A, de Carvalho W, Bourdel MC, Poirier MF (1991) Use of maintenance ECT for elderly depressed patients. Am J Psychiatry 148: 810
Matzen TA, Martin RL, WattTJ, Reilly DK (1988) The use of maintenance electroconvulsive therapy for relapsing depression. Jefferson J Psychiatry 6: 52–58
Moore NP (1943) The maintenance treatment of chronic psychotics by electrically induced convulsions. J Mental Sci 89: 257–269
Monroe RR Jr (1991) Maintenance electroconvulsive therapy. Psychiatr Clin North Am 14 (4): 947–960
Perry P, Tsuang MT (1979) Treatment of unipolar depression following electroconvulsive therapy. J Affect Disord 1: 123–129
Petrides G, Dhossche D, Fink M, Francis A (1994) Continuation ECT: relapse prevention in affective disorders. ConvulsTher 10: 189–194
Pridmore S, Pollard C (1996) Electroconvulsive therapy in parkinson’s disease: 30 month follow-up. J Neurol Neurosurg Psychiatry 60: 693
Rabheru K, Persad E (1997) A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry 42 (5): 476–484
Rasmussen KG, Zorumski CF, Jarvis MR (1993) Electroconvulsive Therapy in Patients with Cerebral Palsy. ConvulsTher 9: 205–208
Sackeim HA (1994) Continuation therapy following ECT: directions for future research. Psychopharmacol Bull 30: 501–521
Schwarz T, Loewenstein J, Isenberg KE (1995) Maintenance ECT: indications and outcome. Convuls Ther 11 (1): 14–23
ScottA (1995) Continuation ECT (maintenance ECT). In: Freeman CP (ed)The ECT Handbook. The Second Report of the Royal College of Psychiatrists’ Special Commitee on ECT. Royal College of Psychiatrists, London, 72
Small JG, Milstein V, Small IF (1991) Electroconvulsive therapy for mania. Psychiatr Clin North Am 14: 887–903
Srinivasan TN, Suresh TR, Jayaram V (1995) Issues in the use of maintenance electroconvulsive therapy. Indian J Psychiatry 37: 139–142
Steffens DC, Krystal AD, Sibert TE, Moore SD, Weiner RD (1995) Cost effectiveness of maintenance ECT. ConvulsTher 11: 283–284
Stevens J, Cheung P, LambertT (2001) Maintenance electroconvulsive therapy in schizophrenia. Aust NZ J Psychiatry 35: 132–133
Stevenson GH, Geoghegan JJ (1951) Prophylactic electroshock: a 5-year study. Am J Psychiatry 107: 743–748
StewartJT (2000) Lithium and maintenance ECT. J ECT 16 (3): 300–301
Swoboda E, Conca A, König P, Waanders R, Hansen M (2001) Maintenance electroconvulsive therapy in affective and schizoaffective disorder. Neuropsychobiology 43: 23–28
Thienhaus OJ, Margletta S, Bennett JA (1990) A study of the clinical efficacy of maintenance ECT. J Clin Psychiatry 51: 141–144
Thornton JE, Mulsant BH, Dealy R, Reynolds CF (1990) A retrospective study of maintenance electroconvulsive therapy in a university-based psychiatric practice. Convuls Ther 6: 121–129
Thuppal M, Fink M (1999) Electroconvulsive therapy and mental retardation. J ECT 15: 140–149 Elektrokonvulsionstherapie als Erhaltungstherapie und Rezidivprophylaxe 461
Vanelle JM, Loo H, Galinowski A, de Carvalho W, Bourdel MC, Brochier P, Bouvet 0, Borchier T, Olie J-P (1994) Maintenance ECT in intractable manic-depressive disorders. Convuls Ther 10: 195–205
van Gorp WG, Altshuler L, Theberge DC, Wilkins J, Dixon W (1998) Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. Arch Gen Psychiatry 1998; 55: 41–46
Wohlfahrt A (1996) Electroconvulsive therapy in compulsive syndromes. A case report. Nervenarzt 67: 397–399
Wolff GE (1957) Results of 4 years active therapy for chronic mental patients and the value of an individual maintenance dose of ECT. Am J Psychiatry 114: 453–458
Young R, Alexopoulos G, Shamoian A (1985) Dissociation of motor response from mood and cognition in a parkinsonian patient treated with ECT. Biol Psychiatry 20: 566–569
Zervas I, Fink M (1991) ECT for refractory Parkinson’s disease. Convuls Ther 7: 222–22
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Wien
About this chapter
Cite this chapter
Baghai et al. (2004). Indikationsabhängige Durchführung und Bewertung der Elektrokonvulsionstherapie. In: Baghai, T.C., Frey, R., Kasper, S., Möller, HJ. (eds) Elektrokonvulsionstherapie. Springer, Vienna. https://doi.org/10.1007/978-3-7091-3752-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-7091-3752-9_4
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-3753-6
Online ISBN: 978-3-7091-3752-9
eBook Packages: Springer Book Archive